| (+)-alpha-tocopherol | decreases activity | ISO | RGD:731006 | 6480464 | alpha-Tocopherol results in decreased activity of PTGS2 protein; more ... | CTD | PMID:15225597 |
| (+)-alpha-viniferin | multiple interactions | ISO | RGD:731007 | 6480464 | alpha-viniferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:14531020 |
| (+)-alpha-viniferin | decreases activity | ISO | RGD:731007 | 6480464 | alpha-viniferin results in decreased activity of PTGS2 protein | CTD | PMID:14531020 |
| (+)-catechin | multiple interactions | ISO | RGD:731006 | 6480464 | Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19557821 |
| (+)-catechin | decreases activity | ISO | RGD:731007 | 6480464 | Catechin results in decreased activity of PTGS2 protein | CTD | PMID:11962253 |
| (+)-catechin | decreases expression | ISO | RGD:731006 | 6480464 | Catechin results in decreased expression of PTGS2 mRNA | CTD | PMID:10920275 |
| (+)-catechin | multiple interactions | ISO | RGD:731006 | 6480464 | Catechin inhibits the reaction [S100B protein results in increased expression of PTGS2 mRNA] | CTD | PMID:17103373 |
| (+)-pilocarpine | increases expression | ISO | RGD:731007 | 6480464 | Pilocarpine results in increased expression of PTGS2 mRNA | CTD | PMID:15193289 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:731006 | 6480464 | epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19557821 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:731007 | 6480464 | epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:20438794 |
| (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of PTGS2 protein | CTD | PMID:15210717 |
| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | 1-Butanol inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein]; more ... | CTD | PMID:15210717 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:731006 | 6480464 | epigallocatechin gallate results in increased expression of PTGS2 protein | CTD | PMID:15210717 |
| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:731006 | 6480464 | epigallocatechin gallate results in decreased expression of PTGS2 mRNA | CTD | PMID:16084531 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:731006 | 6480464 | 1-Butanol inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein]; more ... | CTD | PMID:15210717 |
| (R)-lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA] | CTD | PMID:19735303 |
| (R)-mevalonic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]] | CTD | PMID:18612546 |
| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Norepinephrine | CTD | PMID:15834289 |
| (S)-amphetamine | increases expression | ISO | RGD:731007 | 6480464 | Dextroamphetamine results in increased expression of PTGS2 mRNA | CTD | PMID:12558987 |
| (S)-nicotine | multiple interactions | ISO | RGD:731006 | 6480464 | [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [Nicotine results in increased abundance of Dinoprostone]; more ... | CTD | PMID:18805435 |
| (S)-nicotine | increases expression | ISO | RGD:731006 | 6480464 | Nicotine results in increased expression of PTGS2 mRNA | CTD | PMID:17003101 more ... |
| (S)-nicotine | increases activity | ISO | RGD:731006 | 6480464 | Nicotine results in increased activity of PTGS2 protein | CTD | PMID:17003101 PMID:18805435 |
| (S)-nicotine | multiple interactions | ISO | RGD:731006 | 6480464 | [Atenolol binds to and results in decreased activity of ADRB1 protein] inhibits the reaction [Nicotine results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17003101 |
| (S)-nicotine | multiple interactions | ISO | RGD:731006 | 6480464 | [ICI 118551 binds to and results in decreased activity of ADRB2 protein] inhibits the reaction [Nicotine results in increased expression of PTGS2] | CTD | PMID:17369603 |
| (S)-nicotine | increases expression | ISO | RGD:731006 | 6480464 | Nicotine results in increased expression of PTGS2 mRNA | CTD | PMID:18986645 |
| (S)-nicotine | multiple interactions | ISO | RGD:731006 | 6480464 | Nicotine promotes the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18986645 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of PTGS2 protein | CTD | PMID:19673871 PMID:18068289 |
| (S)-nicotine | increases expression | ISO | RGD:731007 | 6480464 | Nicotine results in increased expression of PTGS2 mRNA | CTD | PMID:17456735 PMID:16254210 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of PTGS2 protein | CTD | PMID:18068289 PMID:19673871 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of PTGS2 mRNA | CTD | PMID:19673871 |
| (S)-nicotine | multiple interactions | EXP | | 6480464 | ferulic acid inhibits the reaction [Nicotine results in increased expression of PTGS2 protein]; more ... | CTD | PMID:18068289 |
| (S)-nicotine | increases expression | ISO | RGD:731007 | 6480464 | Nicotine results in increased expression of PTGS2 mRNA | CTD | PMID:16254210 PMID:17456735 |
| (S)-nicotine | increases expression | ISO | RGD:731006 | 6480464 | Nicotine results in increased expression of PTGS2 protein | CTD | PMID:20727180 |
| (S)-nicotine | increases activity | ISO | RGD:731006 | 6480464 | Nicotine results in increased activity of PTGS2 protein | CTD | PMID:18805435 |
| (S)-nicotine | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [Nicotine results in increased expression of PTGS2 protein] | CTD | PMID:20727180 |
| 1'-acetoxychavicol acetate | multiple interactions | ISO | RGD:731006 | 6480464 | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15905586 |
| 1,2,4-trimethylbenzene | multiple interactions | ISO | RGD:731007 | 6480464 | [S-8 fuel co-treated with Benzene co-treated with Toluene co-treated with ethylbenzene co-treated with Xylenes co-treated with pseudocumene co-treated with Naphthalenes co-treated with phenylcyclohexane] results in increased expression of PTGS2 mRNA | CTD | PMID:17890764 |
| 1,2,4-trimethylbenzene | increases expression | EXP | | 6480464 | pseudocumene results in increased expression of PTGS2 protein | CTD | PMID:17337753 |
| 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1,2-Dimethylhydrazine co-treated with Dietary Fats] results in increased expression of PTGS2 protein | CTD | PMID:22750881 |
| 1,3,5-trinitrobenzene | multiple interactions | ISO | RGD:731007 | 6480464 | Eicosapentaenoic Acid analog inhibits the reaction [sym-trinitrobenzene results in increased expression of PTGS2 mRNA] | CTD | PMID:15890784 |
| 1,4-dithiothreitol | multiple interactions | ISO | RGD:731006 | 6480464 | Dithiothreitol inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]] | CTD | PMID:20584749 |
| 1,4-phenylenediamine | increases expression | ISO | RGD:731006 | 6480464 | 4-phenylenediamine results in increased expression of PTGS2 mRNA | CTD | PMID:19371601 PMID:18571826 |
| 1,4-phenylenediamine | increases expression | ISO | RGD:731006 | 6480464 | 4-phenylenediamine results in increased expression of PTGS2 mRNA | CTD | PMID:18571826 more ... |
| 1,4-phenylenediamine | increases expression | ISO | RGD:731006 | 6480464 | 4-phenylenediamine results in increased expression of PTGS2 mRNA | CTD | PMID:18571826 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:731006 | 6480464 | Dinitrochlorobenzene results in increased expression of PTGS2 mRNA | CTD | PMID:19371601 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:731006 | 6480464 | Dinitrochlorobenzene results in increased expression of PTGS2 mRNA | CTD | PMID:19371601 PMID:20146380 |
| 1-fluoro-2,4-dinitrobenzene | multiple interactions | ISO | RGD:731006 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which affects the susceptibility to Dinitrofluorobenzene | CTD | PMID:21362464 |
| 1-fluoro-2,4-dinitrobenzene | increases expression | ISO | RGD:731006 | 6480464 | Dinitrofluorobenzene results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:21362464 |
| 1-hydroxy-2-naphthoic acid | multiple interactions | ISO | RGD:731007 | 6480464 | 1-hydroxy-2-naphthoic acid analog inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21667204 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | guggulu extract inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PTGS2 protein]; more ... | CTD | PMID:22940226 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | EXP | | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PTGS2 protein | CTD | PMID:22940226 |
| 1-methylnicotinamide | increases expression | EXP | | 6480464 | N(1)-methylnicotinamide results in increased expression of PTGS2 mRNA | CTD | PMID:18385449 |
| 11-deoxycorticosterone | increases expression | EXP | | 6480464 | Desoxycorticosterone results in increased expression of PTGS2 protein | CTD | PMID:16271043 |
| 11-deoxycorticosterone | increases expression | EXP | | 6480464 | Desoxycorticosterone results in increased expression of PTGS2 protein | CTD | PMID:15834289 PMID:16271043 |
| 11-deoxycorticosterone | increases expression | EXP | | 6480464 | Desoxycorticosterone results in increased expression of PTGS2 protein | CTD | PMID:16271043 PMID:15834289 |
| 12(S)-HPETE | multiple interactions | ISO | RGD:731007 | 6480464 | 12-HPETE inhibits the reaction [Sodium Salicylate results in decreased activity of PTGS2 protein]; more ... | CTD | PMID:12538810 |
| 17-HDoHE | multiple interactions | ISO | RGD:731007 | 6480464 | 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:21724996 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:731006 | 6480464 | Ethinyl Estradiol affects the expression of PTGS2 mRNA | CTD | PMID:20170705 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:731006 | 6480464 | Ethinyl Estradiol results in increased expression of PTGS2 mRNA | CTD | PMID:18936297 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol inhibits the reaction [Lipopolysaccharides results in increased secretion of PTGS2 protein] | CTD | PMID:21127968 |
| 17beta-estradiol | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]]; more ... | CTD | PMID:18480072 |
| 17beta-estradiol | increases expression | ISO | RGD:731006 | 6480464 | Estradiol results in increased expression of PTGS2 mRNA | CTD | PMID:15849065 PMID:17872375 |
| 17beta-estradiol | increases expression | ISO | RGD:731006 | 6480464 | Estradiol results in increased expression of PTGS2 protein | CTD | PMID:20951759 |
| 17beta-estradiol | multiple interactions | ISO | RGD:731006 | 6480464 | [Estradiol co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:21513769 |
| 17beta-estradiol | increases expression | ISO | RGD:731007 | 6480464 | Estradiol results in increased expression of PTGS2 protein | CTD | PMID:14758024 PMID:17549036 |
| 17beta-estradiol | multiple interactions | ISO | RGD:731007 | 6480464 | Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:15256495 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of PTGS2 protein | CTD | PMID:16006544 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein | CTD | PMID:16891317 |
| 17beta-estradiol | increases expression | ISO | RGD:731007 | 6480464 | Estradiol results in increased expression of PTGS2 protein | CTD | PMID:17549036 PMID:14758024 |
| 17beta-estradiol | increases expression | ISO | RGD:731007 | 6480464 | Estradiol results in increased expression of PTGS2 mRNA | CTD | PMID:14758024 |
| 17beta-estradiol | multiple interactions | ISO | RGD:731007 | 6480464 | Drugs, Chinese Herbal inhibits the reaction [Estradiol results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:14758024 |
| 17beta-estradiol | multiple interactions | ISO | RGD:731006 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of PTGS2 mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | increases expression | ISO | RGD:731006 | 6480464 | Estradiol results in increased expression of PTGS2 mRNA | CTD | PMID:17872375 PMID:15849065 |
| 17beta-estradiol | decreases expression | ISO | RGD:731006 | 6480464 | Estradiol results in decreased expression of PTGS2 mRNA | CTD | PMID:17872375 |
| 17beta-estradiol | multiple interactions | ISO | RGD:731006 | 6480464 | Estradiol inhibits the reaction [NCOR1 protein binds to PTGS2 promoter]; more ... | CTD | PMID:17872375 |
| 17beta-estradiol | affects expression | ISO | RGD:731006 | 6480464 | Estradiol affects the expression of PTGS2 mRNA | CTD | PMID:14699072 |
| 17beta-estradiol | multiple interactions | ISO | RGD:731006 | 6480464 | [Estradiol co-treated with ESR1 protein] results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:19347870 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | RGD:731006 | 6480464 | Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16317058 |
| 2,2',4,4'-tetrachlorobiphenyl | increases expression | ISO | RGD:731006 | 6480464 | 2,4,2',4'-tetrachlorobiphenyl results in increased expression of PTGS2 mRNA | CTD | PMID:15673847 |
| 2,2',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:731006 | 6480464 | 2,4,2',4'-tetrachlorobiphenyl results in increased expression of and results in increased activity of PTGS2 protein | CTD | PMID:15673847 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | decreases expression | ISO | RGD:731006 | 6480464 | nebivolol results in decreased expression of PTGS2 mRNA | CTD | PMID:17467819 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]]; more ... | CTD | PMID:19056653 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PTGS2 mRNA | CTD | PMID:12128104 PMID:8968384 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:10607728 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:9514655 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 protein | CTD | PMID:10607728 PMID:18606429 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:10607728 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:21104991 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:17407152 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | aurapten inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:20865247 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | zerumbone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:20865247 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:17407152 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of PTGS2 protein | CTD | PMID:18606429 PMID:22430074 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PTGS2 mRNA | CTD | PMID:21846477 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:22262711 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:11133817 PMID:20566336 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:22262711 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PTGS2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:17407152 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:18001219 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19147701 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19372248 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:18388244 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18388244 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:18606429 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | [[Tetrachlorodibenzodioxin binds to AHR protein] which binds to PTGS2 promoter] which results in increased expression of PTGS2 mRNA | CTD | PMID:15213229 PMID:15213229 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19063610 PMID:17407152 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:18001219 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18388244 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19147701 PMID:18938131 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19372248 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:19782052 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19147701 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18388244 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:18691609 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19063610 PMID:19782052 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:18001219 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19162293 PMID:18938131 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18388244 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19147701 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | 2-aminoethoxydiphenyl borate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18388244 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18938131 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:11133817 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of PTGS2 protein | CTD | PMID:17576166 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PTGS2 mRNA; more ... | CTD | PMID:12128104 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [PTGS2 protein results in increased expression of CGA mRNA]; more ... | CTD | PMID:12128104 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]]; more ... | CTD | PMID:11133817 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 protein | CTD | PMID:18606429 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of PTGS2 protein | CTD | PMID:18606429 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | [Tetrachlorodibenzodioxin results in decreased expression of MIR101A] which results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:21602190 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 gene] | CTD | PMID:20819909 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects binding | ISO | RGD:731007 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which binds to PTGS2 promoter | CTD | PMID:15213229 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | [[Tetrachlorodibenzodioxin binds to AHR protein] which binds to PTGS2 promoter] which results in increased expression of PTGS2 mRNA | CTD | PMID:15213229 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:17407152 PMID:19063610 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | Indomethacin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of PTGS2 protein] | CTD | PMID:18617548 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | Forskolin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:17407152 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | AG 1879 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19782052 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 protein | CTD | PMID:17823287 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19782052 PMID:19063610 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731007 | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19063610 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]] | CTD | PMID:19056653 PMID:18001219 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]; more ... | CTD | PMID:18001219 PMID:19056653 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18938131 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18938131 PMID:19147701 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | Linoleic Acid inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]]; more ... | CTD | PMID:18001219 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | EGTA acetoxymethyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18388244 PMID:19147701 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18938131 PMID:19162293 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | AG 1879 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19147701 PMID:18388244 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19147701 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731006 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19147701 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | CTD | PMID:18200517 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:731007 | 6480464 | soyasaponin I inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein] | CTD | PMID:20923188 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:731007 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein | CTD | PMID:20923188 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein | CTD | PMID:11698051 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:731007 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:11717450 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:16782535 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:731007 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:15973123 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein | CTD | PMID:16474422 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:21893697 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein | CTD | PMID:16474422 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:16804969 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:731007 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:11717450 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:22039321 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein | CTD | PMID:11820457 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:731007 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:15973123 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | ISO | RGD:731007 | 6480464 | seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | CTD | PMID:11717450 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein | CTD | PMID:17276891 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:16782535 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein | CTD | PMID:16804969 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | nitroaspirin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | CTD | PMID:22039321 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:16782535 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]]; more ... | CTD | PMID:21893697 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:731007 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:18200517 PMID:15973123 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein | CTD | PMID:17276891 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:16782535 PMID:16804969 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein] | CTD | PMID:16474422 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16782535 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16782535 PMID:16804969 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16804969 PMID:16782535 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | ISO | RGD:731007 | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:15973123 PMID:18200517 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | ISO | RGD:731007 | 6480464 | Butylated Hydroxytoluene results in increased expression of PTGS2 protein | CTD | PMID:11696405 |
| 2,6-di-tert-butyl-4-methylphenol | multiple interactions | EXP | | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Ethanol results in increased expression of PTGS2 mRNA] | CTD | PMID:17067360 |
| 2-(4-hydroxyphenyl)ethanol | multiple interactions | ISO | RGD:731007 | 6480464 | 4-hydroxyphenylethanol inhibits the reaction [[Lipids results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | CTD | PMID:18081942 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:731007 | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:22107987 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:731007 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20737476 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:731007 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:18205790 PMID:17440993 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:731007 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:17440993 PMID:18205790 |
| 2-amino-2-deoxy-D-glucopyranose | decreases glycosylation | ISO | RGD:731006 | 6480464 | Glucosamine results in decreased glycosylation of PTGS2 protein | CTD | PMID:22089456 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:731006 | 6480464 | Glucosamine inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:12681956 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:731006 | 6480464 | [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein | CTD | PMID:17605605 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:731006 | 6480464 | Glucosamine analog results in increased expression of PTGS2 protein alternative form | CTD | PMID:19656660 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of PTGS2 mRNA | CTD | PMID:20737476 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:20737476 |
| 2-arachidonoylglycerol | increases metabolic processing | ISO | RGD:731006 | 6480464 | PTGS2 protein results in increased metabolism of 2-arachidonylglycerol | CTD | PMID:18297109 |
| 2-arachidonoylglycerol | multiple interactions | ISO | RGD:731006 | 6480464 | 2-arachidonylglycerol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased expression of PTGS2 mRNA] | CTD | PMID:21511917 |
| 2-arachidonoylglycerol | multiple interactions | ISO | RGD:731006 | 6480464 | Ibuprofen inhibits the reaction [PTGS2 protein results in increased metabolism of 2-arachidonylglycerol] | CTD | PMID:18297109 |
| 2-butoxyethanol | increases expression | ISO | RGD:731007 | 6480464 | n-butoxyethanol results in increased expression of PTGS2 mRNA | CTD | PMID:19812364 |
| 2-hydroxy-17beta-estradiol | multiple interactions | ISO | RGD:731006 | 6480464 | [2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:18480072 |
| 3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased abundance of Cyclic AMP] | CTD | PMID:21873648 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of PTGS2 protein | CTD | PMID:16396944 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of PTGS2 mRNA | CTD | PMID:19194550 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | affects response to substance | EXP | | 6480464 | PTGS2 protein affects the susceptibility to Puromycin Aminonucleoside | CTD | PMID:16396944 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [Puromycin Aminonucleoside results in increased expression of PTGS2 mRNA] | CTD | PMID:19194550 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | RGD:731007 | 6480464 | Puromycin Aminonucleoside results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:17890881 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:731006 | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21513769 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:731006 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PTGS2 mRNA | CTD | PMID:21513769 PMID:22262711 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:731006 | 6480464 | alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PTGS2 mRNA] | CTD | PMID:22262711 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:731006 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PTGS2 protein; more ... | CTD | PMID:21513769 |
| 3,3',4,4',5-pentachlorobiphenyl | affects expression | ISO | RGD:731006 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl affects the expression of PTGS2 mRNA | CTD | PMID:21703328 |
| 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | RGD:731007 | 6480464 | tetrabromobisphenol A results in increased expression of PTGS2 protein; more ... | CTD | PMID:20077215 |
| 3,3'-diindolylmethane | multiple interactions | ISO | RGD:731006 | 6480464 | 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19056653 |
| 3,3'-diindolylmethane | decreases expression | ISO | RGD:731006 | 6480464 | 3,3'-diindolylmethane results in decreased expression of PTGS2 protein | CTD | PMID:22290291 |
| 3,3'-diindolylmethane | decreases expression | ISO | RGD:731006 | 6480464 | 3,3'-diindolylmethane results in decreased expression of PTGS2 mRNA | CTD | PMID:19056653 |
| 3,4-dihydroxybenzoic acid | multiple interactions | ISO | RGD:731007 | 6480464 | protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of PTGS2 protein] | CTD | PMID:20026373 |
| 3,4-dihydroxybenzoic acid | multiple interactions | ISO | RGD:731007 | 6480464 | protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:22687555 |
| 3-isobutyl-1-methyl-7H-xanthine | increases expression | ISO | RGD:731007 | 6480464 | 1-Methyl-3-isobutylxanthine results in increased expression of PTGS2 mRNA | CTD | PMID:15213229 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:731006 | 6480464 | 1-Methyl-3-isobutylxanthine promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:11095985 |
| 3-methylcholanthrene | increases expression | ISO | RGD:731007 | 6480464 | Methylcholanthrene results in increased expression of PTGS2 mRNA | CTD | PMID:20713471 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:731007 | 6480464 | Oxazolone results in increased expression of PTGS2 mRNA | CTD | PMID:22200888 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | multiple interactions | ISO | RGD:731007 | 6480464 | tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PTGS2 mRNA] | CTD | PMID:22200888 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases activity | ISO | RGD:731006 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of PTGS2 protein | CTD | PMID:15762874 PMID:18805435 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases activity | ISO | RGD:731006 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of PTGS2 protein | CTD | PMID:18805435 PMID:15762874 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:731006 | 6480464 | [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased abundance of Dinoprostone]; more ... | CTD | PMID:18805435 |
| 4-chlorobiphenyl | multiple interactions | ISO | RGD:731006 | 6480464 | [PTGS2 protein results in increased oxidation of 4-chlorobiphenyl metabolite] which results in increased chemical synthesis of Quinones | CTD | PMID:19105592 |
| 4-chlorobiphenyl | increases oxidation | ISO | RGD:731006 | 6480464 | PTGS2 protein results in increased oxidation of 4-chlorobiphenyl metabolite | CTD | PMID:19105592 |
| 4-coumaric acid | decreases expression | ISO | RGD:731006 | 6480464 | 4-coumaric acid results in decreased expression of PTGS2 protein | CTD | PMID:15841493 |
| 4-hydroxy-17beta-estradiol | multiple interactions | ISO | RGD:731006 | 6480464 | [2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:18480072 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:731006 | 6480464 | Fenretinide inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16230421 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:731006 | 6480464 | [PTGS2 protein results in increased chemical synthesis of Dinoprostone] which results in decreased susceptibility to Fenretinide | CTD | PMID:16127422 |
| 4-hydroxyphenyl retinamide | decreases response to substance | ISO | RGD:731006 | 6480464 | PTGS2 protein results in decreased susceptibility to Fenretinide | CTD | PMID:16127422 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:731006 | 6480464 | Fenretinide results in increased expression of PTGS2 mRNA | CTD | PMID:15958647 |
| 4-nitroquinoline N-oxide | multiple interactions | ISO | RGD:731006 | 6480464 | [4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:20043093 |
| 4-nitroquinoline N-oxide | decreases response to substance | ISO | RGD:731007 | 6480464 | PTGS2 gene mutant form results in decreased susceptibility to 4-Nitroquinoline-1-oxide | CTD | PMID:20857495 |
| 4-nitroquinoline N-oxide | multiple interactions | ISO | RGD:731007 | 6480464 | Zinc deficiency inhibits the reaction [PTGS2 gene mutant form results in decreased susceptibility to 4-Nitroquinoline-1-oxide] | CTD | PMID:20857495 |
| 4-nitroquinoline N-oxide | increases expression | ISO | RGD:731007 | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of PTGS2 protein; more ... | CTD | PMID:22561872 |
| 4-phenylbutyric acid | multiple interactions | ISO | RGD:731006 | 6480464 | 4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | CTD | PMID:17709599 |
| 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | multiple interactions | ISO | RGD:731007 | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18305957 |
| 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | multiple interactions | ISO | RGD:731007 | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19063610 |
| 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | multiple interactions | ISO | RGD:731006 | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18938131 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | ISO | RGD:731007 | 6480464 | AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:22025971 |
| 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:731006 | 6480464 | decitabine affects the expression of PTGS2 mRNA | CTD | PMID:17145863 |
| 5-fluorouracil | multiple interactions | ISO | RGD:731006 | 6480464 | acadesine inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]; more ... | CTD | PMID:15896711 |
| 5-fluorouracil | increases response to substance | ISO | RGD:731006 | 6480464 | PTGS2 protein results in increased susceptibility to Fluorouracil | CTD | PMID:12414664 |
| 5-fluorouracil | multiple interactions | ISO | RGD:731006 | 6480464 | PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein]; more ... | CTD | PMID:12414664 |
| 5-fluorouracil | increases expression | ISO | RGD:731006 | 6480464 | Fluorouracil results in increased expression of PTGS2 protein | CTD | PMID:15896711 |
| 5-fluorouracil | increases expression | ISO | RGD:731006 | 6480464 | Fluorouracil results in increased expression of PTGS2 mRNA | CTD | PMID:15846114 |
| 5-fluorouracil | decreases expression | ISO | RGD:731006 | 6480464 | Fluorouracil results in decreased expression of PTGS2 protein | CTD | PMID:16340194 |
| 5-fluorouracil | decreases expression | ISO | RGD:731006 | 6480464 | Fluorouracil results in decreased expression of PTGS2 mRNA | CTD | PMID:15205334 |
| 5-fluorouracil | multiple interactions | ISO | RGD:731006 | 6480464 | [Fluorouracil co-treated with Curcumin] results in decreased expression of PTGS2 protein | CTD | PMID:16340194 |
| 5-fluorouracil | multiple interactions | ISO | RGD:731006 | 6480464 | [Cisplatin co-treated with Fluorouracil] affects the expression of PTGS2 protein | CTD | PMID:16322294 |
| 5-fluorouracil | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin promotes the reaction [Fluorouracil results in decreased phosphorylation of and results in decreased activity of PTGS2 protein] | CTD | PMID:17918158 |
| 6-oxo-prostaglandin F1alpha | multiple interactions | ISO | RGD:731007 | 6480464 | [Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha; more ... | CTD | PMID:16325209 |
| 7,12-dimethyltetraphene | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein] | CTD | PMID:12208745 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:731007 | 6480464 | PTGS2 gene mutant form inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene] | CTD | PMID:21739481 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:731007 | 6480464 | Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein] | CTD | PMID:20043298 |
| 7,12-dimethyltetraphene | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein | CTD | PMID:16891317 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:731007 | 6480464 | [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein; more ... | CTD | PMID:16517061 |
| 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein | CTD | PMID:12208745 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:731006 | 6480464 | [PTGS2 co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of VEGFA | CTD | PMID:12821125 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:731006 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] | CTD | PMID:11112151 |
| 8-epi-prostaglandin F2alpha | multiple interactions | ISO | RGD:731006 | 6480464 | [lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 protein] which results in increased chemical synthesis of 8-epi-prostaglandin F2alpha; more ... | CTD | PMID:8621535 |
| 8-hydroxy-2'-deoxyguanosine | multiple interactions | ISO | RGD:731006 | 6480464 | [[Arachidonic Acid results in increased activity of PTGS2 protein] which results in increased susceptibility to 3,4-Methylenedioxyamphetamine] which results in increased abundance of 8-oxo-7-hydrodeoxyguanosine; more ... | CTD | PMID:21163909 |
| 9-cis-retinoic acid | decreases expression | ISO | RGD:731006 | 6480464 | alitretinoin results in decreased expression of PTGS2 mRNA | CTD | PMID:15982314 |
| AACOCF3 | multiple interactions | ISO | RGD:731006 | 6480464 | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19162293 PMID:18938131 |
| AACOCF3 | multiple interactions | ISO | RGD:731006 | 6480464 | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18938131 PMID:19162293 |
| AACOCF3 | multiple interactions | ISO | RGD:731007 | 6480464 | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19063610 |
| acenaphthoquinone | multiple interactions | ISO | RGD:731006 | 6480464 | [acenaphthenequinone results in increased chemical synthesis of Reactive Oxygen Species] which affects the expression of PTGS2 protein; more ... | CTD | PMID:17082565 |
| acenaphthoquinone | increases expression | ISO | RGD:731006 | 6480464 | acenaphthenequinone results in increased expression of PTGS2 protein | CTD | PMID:17082565 |
| acetaldehyde | increases expression | ISO | RGD:731006 | 6480464 | Acetaldehyde results in increased expression of PTGS2 mRNA | CTD | PMID:17050345 PMID:19110045 |
| acetaldehyde | increases expression | ISO | RGD:731006 | 6480464 | Acetaldehyde results in increased expression of PTGS2 mRNA | CTD | PMID:17050345 more ... |
| acetaldehyde | multiple interactions | ISO | RGD:731006 | 6480464 | Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of PTGS2 mRNA] | CTD | PMID:19110045 |
| acetaldehyde | increases expression | ISO | RGD:731006 | 6480464 | Acetaldehyde results in increased expression of PTGS2 mRNA | CTD | PMID:19110045 PMID:17050345 |
| acetic acid | affects response to substance | ISO | RGD:731007 | 6480464 | PTGS2 protein affects the susceptibility to Acetic Acid | CTD | PMID:16674937 |
| acetic acid | increases expression | EXP | | 6480464 | Acetic Acid results in increased expression of PTGS2 | CTD | PMID:11891194 PMID:10898763 |
| acetic acid | multiple interactions | EXP | | 6480464 | sangre de grado inhibits the reaction [Acetic Acid results in increased expression of PTGS2] | CTD | PMID:10898763 |
| acetic acid | increases expression | EXP | | 6480464 | Acetic Acid results in increased expression of PTGS2 | CTD | PMID:10898763 PMID:11891194 |
| acetic acid | increases expression | EXP | | 6480464 | Acetic Acid results in increased expression of PTGS2 | CTD | PMID:11891194 |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PTGS2 mRNA | CTD | PMID:17595529 more ... |
| acetylsalicylic acid | decreases expression | ISO | RGD:731006 | 6480464 | Aspirin results in decreased expression of PTGS2 mRNA | CTD | PMID:16336399 more ... |
| acetylsalicylic acid | decreases activity | ISO | RGD:731006 | 6480464 | Aspirin results in decreased activity of PTGS2 protein mutant form | CTD | PMID:22245433 |
| acetylsalicylic acid | decreases activity | ISO | RGD:731006 | 6480464 | Aspirin results in decreased activity of PTGS2 protein | CTD | PMID:15843042 PMID:22245433 |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PTGS2 protein | CTD | PMID:17595529 PMID:18482463 |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PTGS2 mRNA | CTD | PMID:12231391 more ... |
| acetylsalicylic acid | increases expression | ISO | RGD:731006 | 6480464 | Aspirin results in increased expression of PTGS2 mRNA | CTD | PMID:17218764 PMID:14742690 |
| acetylsalicylic acid | decreases expression | ISO | RGD:731006 | 6480464 | Aspirin results in decreased expression of PTGS2 protein | CTD | PMID:15861417 more ... |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PTGS2 protein | CTD | PMID:18482463 PMID:17595529 |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PTGS2 mRNA | CTD | PMID:18482463 more ... |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | apple polyphenol extract inhibits the reaction [Aspirin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18482463 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]] | CTD | PMID:21893697 |
| acetylsalicylic acid | affects response to substance | ISO | RGD:731006 | 6480464 | PTGS2 SNP affects the susceptibility to Aspirin | CTD | PMID:19755647 |
| acetylsalicylic acid | decreases expression | ISO | RGD:731006 | 6480464 | Aspirin results in decreased expression of PTGS2 mRNA | CTD | PMID:18197933 more ... |
| acetylsalicylic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Aspirin inhibits the reaction [TNF results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19493461 |
| acetylsalicylic acid | decreases activity | ISO | RGD:731006 | 6480464 | Aspirin results in decreased activity of PTGS2 protein | CTD | PMID:15843042 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Aspirin promotes the reaction [IL1A results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:14742690 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Aspirin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15489888 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Aspirin inhibits the reaction [Arachidonic Acid results in increased activity of PTGS2 protein]; more ... | CTD | PMID:21163909 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Ascorbic Acid inhibits the reaction [Aspirin results in increased expression of PTGS2 mRNA] | CTD | PMID:17218764 |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PTGS2 | CTD | PMID:16804302 |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PTGS2 mRNA | CTD | PMID:12231391 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of PTGS2 protein | CTD | PMID:16310244 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Streptozocin results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20223228 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | [Aspirin co-treated with Hydrochloric Acid] results in increased expression of PTGS2 mRNA | CTD | PMID:9726391 |
| acetylsalicylic acid | increases expression | ISO | RGD:731007 | 6480464 | Aspirin results in increased expression of PTGS2 mRNA | CTD | PMID:10706128 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:731007 | 6480464 | Aspirin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein]; more ... | CTD | PMID:21513785 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:731007 | 6480464 | [Aspirin co-treated with Hydrochloric Acid] results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:15236176 |
| acetylsalicylic acid | affects response to substance | ISO | RGD:731006 | 6480464 | PTGS2 gene SNP affects the susceptibility to Aspirin | CTD | PMID:20485159 |
| acetylsalicylic acid | increases expression | ISO | RGD:731006 | 6480464 | Aspirin results in increased expression of PTGS2 protein | CTD | PMID:14742690 |
| acetylsalicylic acid | decreases expression | ISO | RGD:731006 | 6480464 | Aspirin results in decreased expression of PTGS2 protein | CTD | PMID:12781040 more ... |
| acetylsalicylic acid | increases expression | ISO | RGD:731006 | 6480464 | Aspirin results in increased expression of PTGS2 mRNA | CTD | PMID:14742690 PMID:17218764 |
| acetylsalicylic acid | decreases degradation | ISO | RGD:731006 | 6480464 | Aspirin results in decreased degradation of PTGS2 mRNA | CTD | PMID:14742690 |
| acetylsalicylic acid | decreases expression | ISO | RGD:731006 | 6480464 | Aspirin results in decreased expression of PTGS2 mRNA | CTD | PMID:16336399 PMID:18197933 |
| acetylsalicylic acid | decreases expression | ISO | RGD:731006 | 6480464 | Aspirin results in decreased expression of PTGS2 protein | CTD | PMID:15861417 more ... |
| acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of PTGS2 mRNA | CTD | PMID:17595529 more ... |
| acetylsalicylic acid | decreases expression | ISO | RGD:731006 | 6480464 | Aspirin results in decreased expression of PTGS2 mRNA | CTD | PMID:16336399 more ... |
| acrolein | increases expression | ISO | RGD:731006 | 6480464 | Acrolein results in increased expression of PTGS2 protein; more ... | CTD | PMID:17363696 |
| acrolein | multiple interactions | ISO | RGD:731006 | 6480464 | rottlerin inhibits the reaction [Acrolein results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17363696 |
| actinomycin D | multiple interactions | ISO | RGD:731006 | 6480464 | Dactinomycin inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein] | CTD | PMID:16894348 |
| actinomycin D | multiple interactions | ISO | RGD:731006 | 6480464 | Dactinomycin inhibits the reaction [Zinc results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18513776 |
| actinomycin D | multiple interactions | ISO | RGD:731006 | 6480464 | Dactinomycin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | CTD | PMID:12874281 |
| actinomycin D | multiple interactions | ISO | RGD:731007 | 6480464 | Dactinomycin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:9576062 |
| actinomycin D | multiple interactions | ISO | RGD:731006 | 6480464 | Dactinomycin inhibits the reaction [Sodium Fluoride results in increased expression of PTGS2 mRNA] | CTD | PMID:19376214 |
| actinomycin D | multiple interactions | ISO | RGD:731007 | 6480464 | Dactinomycin inhibits the reaction [nickel chloride results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17065197 |
| actinomycin D | decreases expression | EXP | | 6480464 | Dactinomycin results in decreased expression of PTGS2 mRNA | CTD | PMID:11286988 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | CTD | PMID:11286988 |
| aflatoxin B1 | increases expression | ISO | RGD:731006 | 6480464 | Aflatoxin B1 results in increased expression of PTGS2 mRNA | CTD | PMID:22100608 |
| albuterol | multiple interactions | ISO | RGD:731006 | 6480464 | Albuterol promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] | CTD | PMID:11112151 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:731007 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20737476 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:731007 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:18205790 PMID:17440993 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:731007 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:17440993 PMID:18205790 |
| aldehydo-D-glucosamine | decreases glycosylation | ISO | RGD:731006 | 6480464 | Glucosamine results in decreased glycosylation of PTGS2 protein | CTD | PMID:22089456 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:731006 | 6480464 | Glucosamine inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:12681956 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:731006 | 6480464 | [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein | CTD | PMID:17605605 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:731006 | 6480464 | Glucosamine analog results in increased expression of PTGS2 protein alternative form | CTD | PMID:19656660 |
| aldehydo-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of PTGS2 mRNA | CTD | PMID:20737476 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:20737476 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Cycloheximide inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16894348 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:731006 | 6480464 | azadirachtin inhibits the reaction [Tretinoin results in increased expression of and results in increased activity of PTGS2 protein] | CTD | PMID:21127062 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of PTGS2 protein | CTD | PMID:16847436 |
| all-trans-retinoic acid | affects activity | EXP | | 6480464 | Tretinoin affects the activity of PTGS2 protein | CTD | PMID:16847438 |
| all-trans-retinoic acid | increases expression | ISO | RGD:731006 | 6480464 | Tretinoin results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:16894348 |
| all-trans-retinoic acid | increases expression | ISO | RGD:731006 | 6480464 | Tretinoin metabolite results in increased expression of PTGS2 mRNA | CTD | PMID:15982314 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:731006 | 6480464 | Tretinoin results in decreased expression of PTGS2 mRNA | CTD | PMID:15982314 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:731006 | 6480464 | [Tretinoin co-treated with Lipopolysaccharides] results in decreased expression of PTGS2 protein; more ... | CTD | PMID:16959971 |
| all-trans-retinol | increases expression | EXP | | 6480464 | Vitamin A deficiency results in increased expression of PTGS2 | CTD | PMID:16036340 |
| allopurinol | multiple interactions | EXP | | 6480464 | Allopurinol inhibits the reaction [AGT protein results in increased expression of PTGS2 protein] | CTD | PMID:17244722 |
| allyl alcohol | increases expression | EXP | | 6480464 | allyl alcohol results in increased expression of PTGS2 mRNA | CTD | PMID:11446826 |
| allyl alcohol | multiple interactions | EXP | | 6480464 | allyl alcohol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:11446826 |
| alpha-linolenic acid | increases expression | ISO | RGD:731006 | 6480464 | alpha-Linolenic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:17092368 |
| alpha-linolenic acid | decreases expression | EXP | | 6480464 | alpha-Linolenic Acid results in decreased expression of PTGS2 mRNA | CTD | PMID:14563831 |
| aluminium atom | increases expression | ISO | RGD:731007 | 6480464 | Aluminum results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:16928369 |
| aluminium atom | multiple interactions | ISO | RGD:731007 | 6480464 | meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16928369 |
| aluminium(0) | increases expression | ISO | RGD:731007 | 6480464 | Aluminum results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:16928369 |
| aluminium(0) | multiple interactions | ISO | RGD:731007 | 6480464 | meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16928369 |
| amarogentin | multiple interactions | ISO | RGD:731007 | 6480464 | amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein] | CTD | PMID:16517061 |
| amentoflavone | multiple interactions | ISO | RGD:731006 | 6480464 | [amentoflavone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone | CTD | PMID:12144868 |
| amentoflavone | decreases expression | ISO | RGD:731006 | 6480464 | amentoflavone results in decreased expression of PTGS2 protein; more ... | CTD | PMID:12144868 |
| amiloride | multiple interactions | ISO | RGD:731007 | 6480464 | Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:17237260 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17637181 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine results in decreased activity of and results in decreased expression of PTGS2 protein | CTD | PMID:15067210 |
| amiodarone | increases expression | ISO | RGD:731006 | 6480464 | Amiodarone results in increased expression of PTGS2 mRNA | CTD | PMID:19774075 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PTGS2 mRNA | CTD | PMID:16483693 |
| ammonium hexachloroplatinate | increases expression | ISO | RGD:731006 | 6480464 | ammonium hexachloroplatinate results in increased expression of PTGS2 mRNA | CTD | PMID:19371601 |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] | CTD | PMID:15610444 |
| ampicillin | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [Aspirin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]]; more ... | CTD | PMID:21893697 |
| anandamide | multiple interactions | EXP | | 6480464 | [nimesulide results in decreased expression of PTGS2] which results in increased activity of anandamide | CTD | PMID:17245358 |
| anandamide | increases expression | ISO | RGD:731006 | 6480464 | anandamide results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:16330497 |
| anandamide | increases metabolic processing | ISO | RGD:731007 | 6480464 | PTGS2 results in increased metabolism of anandamide | CTD | PMID:20702753 |
| anandamide | multiple interactions | ISO | RGD:731007 | 6480464 | [nimesulide results in decreased expression of PTGS2] promotes the reaction [FAAH affects the metabolism of anandamide] | CTD | PMID:20702753 |
| anthracene-1,8,9-triol | increases expression | ISO | RGD:731007 | 6480464 | Anthralin results in increased expression of PTGS2 mRNA | CTD | PMID:8989914 |
| antimycin A | increases expression | ISO | RGD:731007 | 6480464 | Antimycin A results in increased expression of PTGS2 mRNA | CTD | PMID:19304788 |
| apigenin | multiple interactions | ISO | RGD:731007 | 6480464 | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:11343698 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [AGT protein results in increased expression of PTGS2 protein] | CTD | PMID:17244722 |
| apocynin | decreases expression | EXP | | 6480464 | acetovanillone results in decreased expression of PTGS2 mRNA | CTD | PMID:21983654 |
| apocynin | multiple interactions | ISO | RGD:731006 | 6480464 | acetovanillone inhibits the reaction [2-aminodiphenyl results in increased expression of PTGS2 protein] | CTD | PMID:22288910 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Streptozocin results in increased expression of PTGS2 protein] | CTD | PMID:18414395 |
| arachidonic acid | increases metabolic processing | ISO | RGD:731007 | 6480464 | PTGS2 protein results in increased metabolism of Arachidonic Acid | CTD | PMID:12538810 |
| arachidonic acid | multiple interactions | ISO | RGD:731006 | 6480464 | [Arachidonic Acid results in increased abundance of Dinoprostone] promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] | CTD | PMID:11112151 |
| arachidonic acid | increases expression | ISO | RGD:731006 | 6480464 | Arachidonic Acid results in increased expression of PTGS2 protein | CTD | PMID:15878913 |
| arachidonic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Dinoprostone promotes the reaction [Arachidonic Acid results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:15878913 |
| arachidonic acid | increases expression | ISO | RGD:731006 | 6480464 | Arachidonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:15878913 more ... |
| arachidonic acid | multiple interactions | ISO | RGD:731007 | 6480464 | Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased metabolism of Arachidonic Acid] | CTD | PMID:12757841 |
| arachidonic acid | increases expression | ISO | RGD:731006 | 6480464 | Arachidonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:18388244 PMID:17092368 |
| arachidonic acid | multiple interactions | ISO | RGD:731006 | 6480464 | [ajulemic acid results in increased expression of PTGS2 mRNA] which results in increased secretion of Arachidonic Acid | CTD | PMID:18840450 |
| arachidonic acid | increases response to substance | ISO | RGD:731007 | 6480464 | PTGS2 results in increased susceptibility to Arachidonic Acid | CTD | PMID:15863457 |
| arachidonic acid | multiple interactions | ISO | RGD:731007 | 6480464 | [nimesulide results in decreased expression of PTGS2] which results in increased abundance of Arachidonic Acid | CTD | PMID:17624748 |
| arachidonic acid | increases expression | ISO | RGD:731007 | 6480464 | Arachidonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:9013627 |
| arachidonic acid | multiple interactions | ISO | RGD:731007 | 6480464 | Arachidonic Acid affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19063610 |
| arachidonic acid | multiple interactions | ISO | RGD:731006 | 6480464 | [PTGS2 co-treated with Arachidonic Acid] results in increased expression of VEGFA | CTD | PMID:12821125 |
| arachidonic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Ibuprofen inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid]; more ... | CTD | PMID:18297109 |
| arachidonic acid | increases metabolic processing | ISO | RGD:731006 | 6480464 | PTGS2 protein results in increased metabolism of Arachidonic Acid | CTD | PMID:18297109 |
| arachidonic acid | increases expression | ISO | RGD:731006 | 6480464 | Arachidonic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:17092368 PMID:18388244 |
| arachidonic acid | multiple interactions | ISO | RGD:731006 | 6480464 | [Arachidonic Acid results in increased activity of PTGS2 protein] which results in increased susceptibility to 3,4-Methylenedioxyamphetamine; more ... | CTD | PMID:21163909 |
| arachidonic acid | increases activity | ISO | RGD:731006 | 6480464 | Arachidonic Acid results in increased activity of PTGS2 protein | CTD | PMID:21163909 |
| arachidonic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Arachidonic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:15684433 |
| arachidonic acid | multiple interactions | ISO | RGD:731007 | 6480464 | 12-HPETE inhibits the reaction [Sodium Salicylate inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid]]; more ... | CTD | PMID:12538810 |
| arsenic atom | increases expression | ISO | RGD:731006 | 6480464 | Arsenic results in increased expression of PTGS2 mRNA | CTD | PMID:18039032 |
| arsenic atom | decreases expression | ISO | RGD:731007 | 6480464 | Arsenic results in decreased expression of PTGS2 mRNA | CTD | PMID:19654921 |
| arsenite(3-) | multiple interactions | ISO | RGD:731007 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of PTGS2 mRNA | CTD | PMID:15894712 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of PTGS2 protein | CTD | PMID:20377179 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [arsenite results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20377179 |
| arsenite(3-) | multiple interactions | ISO | RGD:731007 | 6480464 | MAP3K8 protein affects the reaction [arsenite results in increased expression of PTGS2 protein]; more ... | CTD | PMID:19808956 |
| arsenite(3-) | increases expression | ISO | RGD:731007 | 6480464 | arsenite results in increased expression of PTGS2 protein; more ... | CTD | PMID:17450217 PMID:19808956 |
| arsenite(3-) | decreases expression | ISO | RGD:731007 | 6480464 | arsenite results in decreased expression of PTGS2 mRNA | CTD | PMID:15894712 |
| arsenite(3-) | increases expression | ISO | RGD:731007 | 6480464 | arsenite results in increased expression of PTGS2 mRNA | CTD | PMID:19808956 PMID:17450217 |
| asbestos | increases expression | ISO | RGD:731006 | 6480464 | Asbestos results in increased expression of PTGS2 mRNA | CTD | PMID:22398240 |
| astaxanthin | decreases expression | ISO | RGD:731007 | 6480464 | astaxanthine results in decreased expression of PTGS2 mRNA | CTD | PMID:21621527 |
| atenolol | multiple interactions | ISO | RGD:731006 | 6480464 | [Atenolol binds to and results in decreased activity of ADRB1 protein] inhibits the reaction [Nicotine results in increased expression of PTGS2 protein] | CTD | PMID:17003101 |
| atrazine | affects expression | EXP | | 6480464 | Atrazine affects the expression of PTGS2 | CTD | PMID:21726175 |
| atrazine | multiple interactions | EXP | | 6480464 | kolaviron inhibits the reaction [Atrazine affects the expression of PTGS2] | CTD | PMID:21726175 |
| atropine | multiple interactions | EXP | | 6480464 | Atropine affects the reaction [Indomethacin results in increased expression of PTGS2] | CTD | PMID:16259740 |
| atropine | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] | CTD | PMID:15104355 PMID:15610444 |
| atropine | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased expression of PTGS2 mRNA] | CTD | PMID:15104355 |
| atropine | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased expression of PTGS2] | CTD | PMID:16804302 |
| atropine | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] | CTD | PMID:15610444 PMID:15104355 |
| auranofin | multiple interactions | ISO | RGD:731007 | 6480464 | [lipopolysaccharide A co-treated with Auranofin] results in decreased expression of PTGS2 protein | CTD | PMID:17034761 |
| azadirachtin A | multiple interactions | ISO | RGD:731006 | 6480464 | azadirachtin inhibits the reaction [TNF protein results in increased activity of PTGS2 protein] | CTD | PMID:20018848 |
| azadirachtin A | multiple interactions | ISO | RGD:731006 | 6480464 | azadirachtin inhibits the reaction [Tretinoin results in increased expression of and results in increased activity of PTGS2 protein] | CTD | PMID:21127062 |
| baicalein | multiple interactions | ISO | RGD:731006 | 6480464 | baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | CTD | PMID:19804834 |
| baicalein | multiple interactions | ISO | RGD:731007 | 6480464 | baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA] | CTD | PMID:22369883 |
| baicalin | decreases expression | EXP | | 6480464 | baicalin results in decreased expression of PTGS2 mRNA; more ... | CTD | PMID:22019745 |
| benzene | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [Benzene results in increased expression of PTGS2 protein]; more ... | CTD | PMID:21801798 |
| benzene | multiple interactions | ISO | RGD:731007 | 6480464 | [S-8 fuel co-treated with Benzene co-treated with Toluene co-treated with ethylbenzene co-treated with Xylenes co-treated with pseudocumene co-treated with Naphthalenes co-treated with phenylcyclohexane] results in increased expression of PTGS2 mRNA | CTD | PMID:17890764 |
| benzene | increases expression | ISO | RGD:731006 | 6480464 | Benzene results in increased expression of PTGS2 mRNA | CTD | PMID:20036648 |
| benzene | affects expression | ISO | RGD:731006 | 6480464 | Benzene affects the expression of PTGS2 mRNA | CTD | PMID:21147609 |
| benzene | increases expression | ISO | RGD:731006 | 6480464 | Benzene results in increased expression of PTGS2 protein | CTD | PMID:21801798 |
| benzo[a]pyrene | increases expression | ISO | RGD:731007 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:20371670 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:731007 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731007 | 6480464 | baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA] | CTD | PMID:22369883 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[TNF protein co-treated with Benzo(a)pyrene] results in increased expression of PTGS2 protein]; more ... | CTD | PMID:21745554 |
| benzo[a]pyrene | increases expression | ISO | RGD:731007 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:731007 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:20371670 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:731007 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:20713471 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | increases expression | ISO | RGD:731007 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:20713471 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:731007 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731007 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of PTGS2 mRNA | CTD | PMID:15894712 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731007 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of PTGS2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731006 | 6480464 | Linoleic Acid inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA] | CTD | PMID:18001219 |
| benzo[a]pyrene | increases expression | ISO | RGD:731006 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:20064835 PMID:18001219 |
| benzo[a]pyrene | increases expression | ISO | RGD:731006 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 protein | CTD | PMID:16086235 |
| benzo[a]pyrene | increases expression | ISO | RGD:731006 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:18001219 PMID:20064835 |
| benzo[a]pyrene | increases expression | ISO | RGD:731007 | 6480464 | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | CTD | PMID:21569818 more ... |
| benzoic acid | multiple interactions | ISO | RGD:731007 | 6480464 | Benzoic Acid inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid] | CTD | PMID:12538810 |
| benzoic acid | decreases activity | ISO | RGD:731007 | 6480464 | Benzoic Acid results in decreased activity of PTGS2 protein | CTD | PMID:12538810 |
| berberine | multiple interactions | ISO | RGD:731007 | 6480464 | Berberine inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein] | CTD | PMID:21095217 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:731007 | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20737476 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:731007 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:18205790 PMID:17440993 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:731007 | 6480464 | Glucosamine analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:17440993 PMID:18205790 |
| beta-D-glucosamine | decreases glycosylation | ISO | RGD:731006 | 6480464 | Glucosamine results in decreased glycosylation of PTGS2 protein | CTD | PMID:22089456 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:731006 | 6480464 | Glucosamine inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:12681956 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:731006 | 6480464 | [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein | CTD | PMID:17605605 |
| beta-D-glucosamine | increases expression | ISO | RGD:731006 | 6480464 | Glucosamine analog results in increased expression of PTGS2 protein alternative form | CTD | PMID:19656660 |
| beta-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of PTGS2 mRNA | CTD | PMID:20737476 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:20737476 |
| bicalutamide | multiple interactions | ISO | RGD:731006 | 6480464 | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | CTD | PMID:16317058 |
| bifenthrin | multiple interactions | EXP | | 6480464 | bifenthrin analog inhibits the reaction [CGA results in increased expression of PTGS2 mRNA] | CTD | PMID:21871944 |
| bifenthrin | multiple interactions | EXP | | 6480464 | bifenthrin inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21251947 |
| biphenyl-2,2'-diol | multiple interactions | ISO | RGD:731007 | 6480464 | 2,2'-biphenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2] | CTD | PMID:19528508 |
| biphenyl-4,4'-diol | multiple interactions | ISO | RGD:731007 | 6480464 | [4,4'-dihydroxybiphenyl co-treated with Lipopolysaccharides] results in increased expression of PTGS2 | CTD | PMID:19528508 |
| biphenyl-4-amine | increases metabolic processing | ISO | RGD:731006 | 6480464 | PTGS2 protein results in increased metabolism of 4-biphenylamine | CTD | PMID:11159734 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:731007 | 6480464 | Mustard Gas results in increased expression of PTGS2 mRNA | CTD | PMID:18955075 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of PTGS2 protein | CTD | PMID:20659490 |
| bis(2-chloroethyl) sulfide | increases response to substance | ISO | RGD:731007 | 6480464 | PTGS2 protein results in increased susceptibility to Mustard Gas | CTD | PMID:15451306 |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:731007 | 6480464 | [celecoxib results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Mustard Gas | CTD | PMID:15451306 |
| bisdemethoxycurcumin | multiple interactions | ISO | RGD:731007 | 6480464 | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18449507 |
| bisphenol A | increases expression | ISO | RGD:731006 | 6480464 | bisphenol A results in increased expression of PTGS2 mRNA | CTD | PMID:19415476 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PTGS2 mRNA | CTD | PMID:20096755 |
| bisphenol A | multiple interactions | ISO | RGD:731006 | 6480464 | Drugs, Chinese Herbal inhibits the reaction [bisphenol A results in increased expression of PTGS2 mRNA] | CTD | PMID:19415476 |
| bisphenol A | affects expression | ISO | RGD:731006 | 6480464 | bisphenol A affects the expression of PTGS2 mRNA | CTD | PMID:20170705 |
| bucladesine | multiple interactions | ISO | RGD:731006 | 6480464 | Bucladesine promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:11095985 |
| budesonide | multiple interactions | ISO | RGD:731007 | 6480464 | Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 mRNA] | CTD | PMID:20061444 |
| budesonide | multiple interactions | EXP | | 6480464 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | CTD | PMID:15734790 |
| bupivacaine | increases expression | ISO | RGD:731006 | 6480464 | Bupivacaine results in increased expression of PTGS2 mRNA | CTD | PMID:18165598 |
| bupivacaine | multiple interactions | ISO | RGD:731006 | 6480464 | [Bupivacaine results in increased expression of PTGS2] which results in increased abundance of Dinoprostone | CTD | PMID:18165598 |
| busulfan | increases expression | ISO | RGD:731006 | 6480464 | Busulfan results in increased expression of PTGS2 mRNA | CTD | PMID:12966370 |
| butan-1-ol | multiple interactions | ISO | RGD:731006 | 6480464 | 1-Butanol inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein] | CTD | PMID:17640750 |
| butan-1-ol | multiple interactions | EXP | | 6480464 | 1-Butanol inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | CTD | PMID:15210717 |
| butan-1-ol | multiple interactions | EXP | | 6480464 | 1-Butanol inhibits the reaction [AGT protein results in increased expression of PTGS2 protein] | CTD | PMID:14613874 |
| butan-1-ol | multiple interactions | ISO | RGD:731007 | 6480464 | 1-Butanol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:12872987 |
| butan-1-ol | multiple interactions | ISO | RGD:731006 | 6480464 | 1-Butanol inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | CTD | PMID:11854442 |
| butan-1-ol | multiple interactions | ISO | RGD:731006 | 6480464 | 1-Butanol inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | CTD | PMID:15210717 |
| butyric acid | increases expression | ISO | RGD:731006 | 6480464 | Butyric Acid results in increased expression of PTGS2 mRNA | CTD | PMID:17928716 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Cadmium results in increased expression of PTGS2 protein] | CTD | PMID:16226777 |
| cadmium atom | increases expression | ISO | RGD:731006 | 6480464 | Cadmium results in increased expression of PTGS2 mRNA | CTD | PMID:18791180 PMID:21694771 |
| cadmium atom | increases activity | ISO | RGD:731007 | 6480464 | Cadmium results in increased activity of PTGS2 protein | CTD | PMID:11997384 PMID:15212812 |
| cadmium atom | increases ubiquitination | ISO | RGD:731007 | 6480464 | Cadmium results in increased ubiquitination of PTGS2 protein | CTD | PMID:11997384 |
| cadmium atom | multiple interactions | ISO | RGD:731007 | 6480464 | [Cadmium results in increased expression of PTGS2 mRNA] which results in increased abundance of Dinoprostone | CTD | PMID:11997384 |
| cadmium atom | affects glycosylation | ISO | RGD:731007 | 6480464 | Cadmium affects the glycosylation of PTGS2 protein | CTD | PMID:11997384 |
| cadmium atom | increases activity | ISO | RGD:731007 | 6480464 | Cadmium results in increased activity of PTGS2 protein | CTD | PMID:15212812 PMID:11997384 |
| cadmium atom | increases expression | ISO | RGD:731007 | 6480464 | Cadmium results in increased expression of PTGS2 mRNA | CTD | PMID:11351503 PMID:11997384 |
| cadmium atom | multiple interactions | ISO | RGD:731007 | 6480464 | [Cadmium results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone | CTD | PMID:15212812 |
| cadmium atom | multiple interactions | ISO | RGD:731007 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16777358 |
| cadmium atom | decreases expression | ISO | RGD:731006 | 6480464 | Cadmium results in decreased expression of PTGS2 mRNA | CTD | PMID:16439709 |
| cadmium atom | increases expression | ISO | RGD:731006 | 6480464 | Cadmium results in increased expression of PTGS2 mRNA | CTD | PMID:18791180 |
| cadmium atom | multiple interactions | ISO | RGD:731006 | 6480464 | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased expression of PTGS2 mRNA] | CTD | PMID:18791180 |
| cadmium dichloride | increases expression | ISO | RGD:731006 | 6480464 | Cadmium Chloride results in increased expression of PTGS2 mRNA | CTD | PMID:18560533 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | [Silicon Dioxide analog co-treated with Cadmium Chloride] results in increased expression of PTGS2 protein | CTD | PMID:22898625 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of PTGS2 protein | CTD | PMID:22898625 |
| cadmium dichloride | increases expression | ISO | RGD:731007 | 6480464 | Cadmium Chloride results in increased expression of PTGS2 mRNA | CTD | PMID:15081267 PMID:16777358 |
| cadmium dichloride | increases expression | ISO | RGD:731007 | 6480464 | Cadmium Chloride results in increased expression of PTGS2 mRNA | CTD | PMID:16777358 PMID:15081267 |
| cadmium dichloride | increases expression | ISO | RGD:731007 | 6480464 | Cadmium Chloride results in increased expression of PTGS2 protein | CTD | PMID:16777358 |
| cadmium dichloride | multiple interactions | ISO | RGD:731007 | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Cadmium Chloride results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16777358 |
| cadmium dichloride | multiple interactions | ISO | RGD:731006 | 6480464 | TNF affects the reaction [Cadmium Chloride results in increased expression of PTGS2 mRNA] | CTD | PMID:18560533 |
| cadmium sulfate | multiple interactions | ISO | RGD:731007 | 6480464 | [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [cadmium sulfate results in increased expression of PTGS2 protein]] which results in decreased abundance of Dinoprostone; more ... | CTD | PMID:14687664 |
| cadmium sulfate | increases expression | ISO | RGD:731007 | 6480464 | cadmium sulfate results in increased expression of PTGS2; more ... | CTD | PMID:14687664 |
| caffeine | decreases expression | ISO | RGD:731006 | 6480464 | Caffeine results in decreased expression of PTGS2 protein | CTD | PMID:21561856 |
| caffeine | multiple interactions | ISO | RGD:731007 | 6480464 | Caffeine inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; more ... | CTD | PMID:22974838 |
| calciol | increases expression | ISO | RGD:731007 | 6480464 | Cholecalciferol results in increased expression of PTGS2 mRNA | CTD | PMID:16508948 PMID:17170073 |
| calciol | increases expression | ISO | RGD:731007 | 6480464 | Cholecalciferol results in increased expression of PTGS2 mRNA | CTD | PMID:17170073 PMID:16508948 |
| calcitriol | increases expression | ISO | RGD:731006 | 6480464 | Calcitriol results in increased expression of PTGS2 mRNA | CTD | PMID:16002434 |
| calcitriol | increases response to substance | EXP | | 6480464 | PTGS2 protein results in increased susceptibility to Calcitriol | CTD | PMID:11455568 |
| calcium atom | multiple interactions | ISO | RGD:731006 | 6480464 | Calcium affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | CTD | PMID:12493747 |
| calcium atom | multiple interactions | ISO | RGD:731007 | 6480464 | Calcium deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19782052 |
| calcium(0) | multiple interactions | ISO | RGD:731006 | 6480464 | Calcium affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | CTD | PMID:12493747 |
| calcium(0) | multiple interactions | ISO | RGD:731007 | 6480464 | Calcium deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19782052 |
| candesartan | multiple interactions | ISO | RGD:731007 | 6480464 | candesartan inhibits the reaction [AGT results in increased expression of PTGS2 protein] | CTD | PMID:12065685 |
| capecitabine | decreases expression | ISO | RGD:731006 | 6480464 | capecitabine results in decreased expression of PTGS2 protein | CTD | PMID:17904787 |
| capsaicin | multiple interactions | ISO | RGD:731007 | 6480464 | Capsaicin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:14530214 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of PTGS2 protein | CTD | PMID:17141941 PMID:20712533 |
| capsaicin | multiple interactions | EXP | | 6480464 | NOX3 mutant form inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20712533 |
| capsaicin | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Capsaicin] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | CTD | PMID:19723084 |
| capsaicin | decreases expression | ISO | RGD:731007 | 6480464 | Capsaicin results in decreased expression of PTGS2 mRNA | CTD | PMID:17719033 |
| capsaicin | decreases expression | EXP | | 6480464 | Capsaicin results in decreased expression of PTGS2 protein | CTD | PMID:11125845 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:20712533 |
| capsaicin | multiple interactions | ISO | RGD:731006 | 6480464 | Capsaicin promotes the reaction [Genistein results in decreased expression of PTGS2 protein] | CTD | PMID:19723084 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of PTGS2 protein | CTD | PMID:20712533 PMID:17141941 |
| capsaicin | multiple interactions | EXP | | 6480464 | Botulinum Toxins, Type A inhibits the reaction [Capsaicin results in increased expression of PTGS2 protein] | CTD | PMID:17141941 |
| capsaicin | increases expression | ISO | RGD:731007 | 6480464 | Capsaicin results in increased expression of PTGS2 protein; more ... | CTD | PMID:20660715 |
| capsaicin | multiple interactions | ISO | RGD:731007 | 6480464 | Capsaicin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20660715 |
| carbachol | affects expression | EXP | | 6480464 | Carbachol affects the expression of PTGS2 protein | CTD | PMID:16023590 |
| carboplatin | decreases response to substance | ISO | RGD:731006 | 6480464 | PTGS2 protein results in decreased susceptibility to Carboplatin | CTD | PMID:18089846 |
| carboplatin | multiple interactions | ISO | RGD:731006 | 6480464 | wortmannin inhibits the reaction [PTGS2 protein results in decreased susceptibility to Carboplatin] | CTD | PMID:18089846 |
| carnosic acid | multiple interactions | ISO | RGD:731007 | 6480464 | salvin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:21375325 |
| carrageenan | multiple interactions | EXP | | 6480464 | Carrageenan inhibits the reaction [Raloxifene results in increased expression of PTGS2 protein] | CTD | PMID:15860553 |
| carrageenan | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA] | CTD | PMID:19735303 |
| carrageenan | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA] | CTD | PMID:18814970 |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of PTGS2 mRNA | CTD | PMID:17258197 more ... |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of PTGS2 protein | CTD | PMID:15860553 more ... |
| carrageenan | multiple interactions | EXP | | 6480464 | dragon's blood inhibits the reaction [Carrageenan results in increased expression of PTGS2 protein] | CTD | PMID:22198006 |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of PTGS2 protein | CTD | PMID:17258197 more ... |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of PTGS2 protein | CTD | PMID:22198006 more ... |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of PTGS2 protein | CTD | PMID:15860553 PMID:17258197 |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of PTGS2 protein | CTD | PMID:15860553 more ... |
| carrageenan | multiple interactions | EXP | | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Carrageenan results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17258197 |
| carrageenan | multiple interactions | EXP | | 6480464 | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:14654164 |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of PTGS2 protein | CTD | PMID:17258197 PMID:15860553 |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of PTGS2 mRNA | CTD | PMID:17258197 |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:16004971 more ... |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | celecoxib promotes the reaction [arsenic trioxide results in decreased expression of PTGS2 protein]; more ... | CTD | PMID:21540248 |
| celecoxib | decreases activity | ISO | RGD:731007 | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:21268125 |
| celecoxib | multiple interactions | ISO | RGD:731007 | 6480464 | [celecoxib results in decreased activity of PTGS2 protein] which results in decreased phosphorylation of STAT3 protein; more ... | CTD | PMID:21268125 |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib results in decreased expression of PTGS2 | CTD | PMID:16144915 more ... |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:15197583 more ... |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of PTGS2 protein mutant form | CTD | PMID:22245433 |
| celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:12960143 more ... |
| celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:12960143 more ... |
| celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:12960143 more ... |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:19682443 more ... |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib results in decreased expression of PTGS2 | CTD | PMID:17224647 more ... |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:18848576 more ... |
| celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:19356723 more ... |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:12888902 more ... |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:20844471 more ... |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:18485224 more ... |
| celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:17908994 more ... |
| celecoxib | decreases activity | EXP | | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:12967936 PMID:12727271 |
| celecoxib | multiple interactions | EXP | | 6480464 | Ampicillin inhibits the reaction [celecoxib promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]] | CTD | PMID:21893697 |
| celecoxib | multiple interactions | ISO | RGD:731007 | 6480464 | celecoxib results in decreased susceptibility to [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:20883674 |
| celecoxib | decreases expression | ISO | RGD:731007 | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:15570007 PMID:15126378 |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:19024521 more ... |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:15870389 more ... |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | [celecoxib results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone | CTD | PMID:21177414 more ... |
| celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of PTGS2 mRNA | CTD | PMID:19201774 |
| celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:17908994 more ... |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [Puromycin Aminonucleoside results in increased expression of PTGS2 mRNA] | CTD | PMID:19194550 |
| celecoxib | decreases activity | EXP | | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:12727271 PMID:12967936 |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [Dietary Fats results in increased expression of PTGS2 mRNA] | CTD | PMID:19247274 |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [PTGS2 protein affects the abundance of lipoxin A4] | CTD | PMID:15326064 |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [Dietary Fats results in increased expression of PTGS2] | CTD | PMID:20039930 |
| celecoxib | decreases expression | ISO | RGD:731007 | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:15126378 PMID:15570007 |
| celecoxib | multiple interactions | EXP | | 6480464 | [celecoxib co-treated with sulindac sulfone] results in decreased expression of PTGS2 protein; more ... | CTD | PMID:17908994 |
| celecoxib | decreases expression | ISO | RGD:731007 | 6480464 | celecoxib results in decreased expression of PTGS2 mRNA | CTD | PMID:17201140 |
| celecoxib | multiple interactions | ISO | RGD:731007 | 6480464 | [celecoxib results in decreased activity of PTGS2 protein] which results in increased susceptibility to Acetaminophen | CTD | PMID:11743745 |
| celecoxib | multiple interactions | ISO | RGD:731007 | 6480464 | [celecoxib results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Mustard Gas | CTD | PMID:15451306 |
| celecoxib | decreases activity | ISO | RGD:731007 | 6480464 | celecoxib results in decreased activity of PTGS2 protein alternative form | CTD | PMID:11743745 |
| celecoxib | multiple interactions | ISO | RGD:731007 | 6480464 | celecoxib inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein]; more ... | CTD | PMID:21513785 |
| celecoxib | increases response to substance | ISO | RGD:731006 | 6480464 | PTGS2 results in increased susceptibility to celecoxib | CTD | PMID:17612393 |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | PTGS2 protein affects the reaction [celecoxib results in increased expression of GDF15 mRNA]; more ... | CTD | PMID:18089846 |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | [FEC protocol co-treated with celecoxib] results in decreased expression of PTGS2 protein | CTD | PMID:16507397 |
| celecoxib | increases expression | ISO | RGD:731006 | 6480464 | celecoxib results in increased expression of PTGS2 protein | CTD | PMID:18202791 |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | [celecoxib results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone | CTD | PMID:12417326 more ... |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:19682443 more ... |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib results in decreased expression of PTGS2 mRNA | CTD | PMID:19635192 |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib results in decreased expression of PTGS2 | CTD | PMID:17285134 more ... |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:21177414 more ... |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib analog results in decreased expression of PTGS2 protein | CTD | PMID:19682443 |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of and results in decreased expression of PTGS2 protein; more ... | CTD | PMID:19522023 |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | celecoxib inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | CTD | PMID:16004971 |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | celecoxib inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15489888 |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | [celecoxib analog results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone | CTD | PMID:18485224 |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib analog results in decreased activity of PTGS2 protein | CTD | PMID:18485224 |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | celecoxib binds to and results in decreased activity of PTGS2 protein | CTD | PMID:15465334 |
| celecoxib | decreases activity | ISO | RGD:731006 | 6480464 | celecoxib results in decreased activity of PTGS2 protein | CTD | PMID:15197583 more ... |
| celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of PTGS2 protein | CTD | PMID:18988310 more ... |
| celecoxib | decreases expression | ISO | RGD:731006 | 6480464 | celecoxib results in decreased expression of PTGS2 | CTD | PMID:17224647 more ... |
| celecoxib | multiple interactions | ISO | RGD:731006 | 6480464 | [celecoxib results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone | CTD | PMID:18485224 more ... |
| ceruletide | increases expression | EXP | | 6480464 | Caerulein results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:14751415 |
| cetylpyridinium | multiple interactions | ISO | RGD:731006 | 6480464 | [Triclosan co-treated with Cetylpyridinium] inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16253096 |
| chenodeoxycholic acid | increases expression | ISO | RGD:731007 | 6480464 | Chenodeoxycholic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:21224055 |
| chloramphenicol | multiple interactions | ISO | RGD:731007 | 6480464 | Chloramphenicol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of PTGS2 mRNA] | CTD | PMID:21767162 |
| chlorobenzene | increases expression | ISO | RGD:731006 | 6480464 | chlorobenzene results in increased expression of PTGS2 protein; more ... | CTD | PMID:19800902 |
| chlorogenic acid | multiple interactions | ISO | RGD:731007 | 6480464 | Chlorogenic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of PTGS2 protein] | CTD | PMID:20026373 |
| chlorogenic acid | multiple interactions | EXP | | 6480464 | Chlorogenic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:23146752 |
| choline | multiple interactions | EXP | | 6480464 | [Choline deficiency co-treated with Amino Acids, Peptides, and Proteins] results in increased expression of PTGS2 protein | CTD | PMID:11872629 |
| choline | multiple interactions | ISO | RGD:731007 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased expression of PTGS2 mRNA | CTD | PMID:20697377 |
| chondroitin sulfate | multiple interactions | ISO | RGD:731006 | 6480464 | [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein | CTD | PMID:17605605 |
| chromium(6+) | multiple interactions | ISO | RGD:731007 | 6480464 | [chromium hexavalent ion promotes the reaction [JUN protein binds to PTGS2 promoter]] which results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:22472290 PMID:22472290 |
| chromium(6+) | increases expression | ISO | RGD:731007 | 6480464 | chromium hexavalent ion results in increased expression of PTGS2 protein; more ... | CTD | PMID:22472290 |
| chromium(6+) | increases expression | ISO | RGD:731006 | 6480464 | chromium hexavalent ion results in increased expression of PTGS2 protein | CTD | PMID:22472290 |
| chromium(6+) | multiple interactions | ISO | RGD:731007 | 6480464 | chromium hexavalent ion promotes the reaction [JUN protein binds to PTGS2 promoter]; more ... | CTD | PMID:22472290 |
| ciglitazone | multiple interactions | ISO | RGD:731006 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [ciglitazone results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16417216 |
| ciglitazone | multiple interactions | ISO | RGD:731006 | 6480464 | ciglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:11278336 |
| ciglitazone | multiple interactions | ISO | RGD:731006 | 6480464 | ciglitazone results in increased expression of and results in increased activity of PTGS2 protein; more ... | CTD | PMID:12517972 |
| ciglitazone | increases expression | ISO | RGD:731006 | 6480464 | ciglitazone results in increased expression of PTGS2 protein | CTD | PMID:11840453 more ... |
| ciglitazone | increases expression | ISO | RGD:731006 | 6480464 | ciglitazone results in increased expression of [IL1B protein results in increased expression of PTGS2 protein] | CTD | PMID:12517972 |
| ciglitazone | multiple interactions | EXP | | 6480464 | ciglitazone promotes the reaction [[PAR-1-activating peptide results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; more ... | CTD | PMID:19954759 |
| ciglitazone | multiple interactions | ISO | RGD:731007 | 6480464 | ciglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:12031542 |
| ciglitazone | increases expression | ISO | RGD:731006 | 6480464 | ciglitazone results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:11840453 PMID:16417216 |
| ciglitazone | multiple interactions | ISO | RGD:731006 | 6480464 | [Cisplatin co-treated with ciglitazone] results in decreased expression of PTGS2 | CTD | PMID:21681689 |
| ciglitazone | increases expression | ISO | RGD:731006 | 6480464 | ciglitazone results in increased expression of PTGS2 protein; more ... | CTD | PMID:16417216 PMID:11840453 |
| ciglitazone | multiple interactions | ISO | RGD:731006 | 6480464 | ciglitazone promotes the reaction [PPARA protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:11840453 |
| ciglitazone | affects expression | ISO | RGD:731006 | 6480464 | ciglitazone affects the expression of PTGS2 protein | CTD | PMID:21067863 |
| cilostazol | multiple interactions | ISO | RGD:731007 | 6480464 | cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:21256160 |
| ciprofibrate | increases expression | ISO | RGD:731007 | 6480464 | ciprofibrate analog results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:9013627 |
| cis-caffeic acid | multiple interactions | ISO | RGD:731007 | 6480464 | caffeic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | CTD | PMID:22036979 |
| cis-caffeic acid | multiple interactions | ISO | RGD:731006 | 6480464 | caffeic acid promotes the reaction [Thapsigargin results in decreased expression of PTGS2 mRNA] | CTD | PMID:19442820 |
| cisplatin | multiple interactions | ISO | RGD:731006 | 6480464 | [Cisplatin co-treated with ciglitazone] results in decreased expression of PTGS2 | CTD | PMID:21681689 |
| cisplatin | increases expression | ISO | RGD:731007 | 6480464 | Cisplatin results in increased expression of PTGS2 mRNA | CTD | PMID:21570986 PMID:21151649 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of PTGS2 protein | CTD | PMID:21272267 PMID:21256724 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of PTGS2 mRNA; more ... | CTD | PMID:21256724 PMID:21272267 |
| cisplatin | increases expression | ISO | RGD:731007 | 6480464 | Cisplatin results in increased expression of PTGS2 protein | CTD | PMID:20942565 |
| cisplatin | multiple interactions | ISO | RGD:731007 | 6480464 | PTGS2 protein promotes the reaction [Cisplatin results in increased expression of IL1B protein]; more ... | CTD | PMID:20844471 |
| cisplatin | multiple interactions | ISO | RGD:731007 | 6480464 | IL6 gene mutant form promotes the reaction [Cisplatin results in increased expression of PTGS2 mRNA] | CTD | PMID:21570986 |
| cisplatin | increases expression | ISO | RGD:731007 | 6480464 | Cisplatin results in increased expression of PTGS2 mRNA | CTD | PMID:21151649 PMID:21570986 |
| cisplatin | multiple interactions | ISO | RGD:731007 | 6480464 | diphenylmethyl selenocyanate inhibits the reaction [Cisplatin results in increased expression of PTGS2 protein] | CTD | PMID:20942565 |
| cisplatin | decreases response to substance | ISO | RGD:731006 | 6480464 | PTGS2 results in decreased susceptibility to Cisplatin | CTD | PMID:15517878 |
| cisplatin | increases expression | ISO | RGD:731006 | 6480464 | Cisplatin results in increased expression of PTGS2 mRNA | CTD | PMID:15846114 |
| cisplatin | increases expression | ISO | RGD:731006 | 6480464 | Cisplatin results in increased expression of PTGS2 protein | CTD | PMID:20844471 |
| cisplatin | multiple interactions | ISO | RGD:731006 | 6480464 | [PTGS2 protein results in increased expression of ABCC2 protein] which results in increased susceptibility to Cisplatin; more ... | CTD | PMID:18695918 |
| cisplatin | multiple interactions | ISO | RGD:731006 | 6480464 | [Cisplatin co-treated with Fluorouracil] affects the expression of PTGS2 protein | CTD | PMID:16322294 |
| clofibrate | increases expression | ISO | RGD:731007 | 6480464 | Clofibrate results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:9013627 |
| clofibrate | multiple interactions | ISO | RGD:731007 | 6480464 | Clofibrate inhibits the reaction [[Fatty Acids, Nonesterified binds to ALB protein] which results in increased expression of PTGS2 mRNA] | CTD | PMID:21338618 |
| clofibrate | multiple interactions | EXP | | 6480464 | Clofibrate inhibits the reaction [[Ethanol co-treated with Fish Oils] results in increased expression of PTGS2 protein] | CTD | PMID:15016835 |
| cobalt atom | multiple interactions | ISO | RGD:731006 | 6480464 | [tungsten carbide binds to Cobalt] which results in increased expression of PTGS2 mRNA | CTD | PMID:20105288 |
| cobalt atom | multiple interactions | ISO | RGD:731006 | 6480464 | [tungsten carbide co-treated with Cobalt] results in decreased expression of PTGS2 mRNA | CTD | PMID:18078969 |
| cobalt dichloride | multiple interactions | ISO | RGD:731006 | 6480464 | 1-Butanol inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17640750 |
| cobalt dichloride | increases expression | ISO | RGD:731006 | 6480464 | cobaltous chloride results in increased expression of PTGS2 mRNA | CTD | PMID:20105288 PMID:23052192 |
| cobalt dichloride | increases expression | ISO | RGD:731006 | 6480464 | cobaltous chloride results in increased expression of PTGS2 protein | CTD | PMID:17640750 PMID:21533553 |
| cobalt dichloride | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein]; more ... | CTD | PMID:21533553 |
| cobalt dichloride | increases expression | ISO | RGD:731006 | 6480464 | cobaltous chloride results in increased expression of PTGS2 protein | CTD | PMID:17640750 |
| cobalt dichloride | increases expression | ISO | RGD:731006 | 6480464 | cobaltous chloride results in increased expression of PTGS2 mRNA | CTD | PMID:20105288 |
| copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of PTGS2 protein | CTD | PMID:20302851 |
| copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of PTGS2 protein | CTD | PMID:19609832 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of PTGS2 protein | CTD | PMID:20302851 |
| copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of PTGS2 protein | CTD | PMID:19609832 |
| corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:15755911 |
| cortisol | multiple interactions | ISO | RGD:731006 | 6480464 | Hydrocortisone inhibits the reaction [EGF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:17805209 |
| crocidolite asbestos | increases expression | ISO | RGD:731006 | 6480464 | Asbestos, Crocidolite results in increased expression of PTGS2 mRNA | CTD | PMID:18687144 |
| crocidolite asbestos | increases expression | ISO | RGD:731006 | 6480464 | Asbestos, Crocidolite results in increased expression of PTGS2 mRNA | CTD | PMID:18687144 PMID:20831825 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16782535 PMID:16804969 |
| curcumin | decreases expression | ISO | RGD:731007 | 6480464 | Curcumin results in decreased expression of PTGS2 mRNA | CTD | PMID:18549505 |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:18549505 |
| curcumin | decreases expression | ISO | RGD:731007 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:17440100 more ... |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:16309195 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:15841493 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 mRNA | CTD | PMID:15911101 more ... |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15489888 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:18226269 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 mRNA | CTD | PMID:19250217 more ... |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:17291458 more ... |
| curcumin | decreases expression | ISO | RGD:731007 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:18829502 more ... |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:16309195 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 mRNA | CTD | PMID:17671742 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:16340194 more ... |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:17436566 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:16340194 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 mRNA | CTD | PMID:17671737 more ... |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15489888 more ... |
| curcumin | decreases expression | ISO | RGD:731007 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:18829502 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:18226269 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 mRNA | CTD | PMID:17671742 more ... |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:17291458 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PTGS2 mRNA | CTD | PMID:18001810 PMID:17190766 |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:17436566 PMID:16934760 |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:15841493 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 mRNA | CTD | PMID:17671742 more ... |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:17640567 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin analog results in decreased expression of PTGS2 mRNA | CTD | PMID:19250217 PMID:17671737 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Quartz results in increased expression of PTGS2 mRNA] | CTD | PMID:18001810 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:18368483 |
| curcumin | decreases expression | ISO | RGD:731007 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:17885582 more ... |
| curcumin | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA] | CTD | PMID:17827730 |
| curcumin | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Azoxymethane] results in increased expression of PTGS2 mRNA | CTD | PMID:17190766 |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | CTD | PMID:18200517 |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:16934760 PMID:17436566 |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:16678799 |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | [Curcumin co-treated with gemcitabine] results in decreased expression of PTGS2 protein | CTD | PMID:17440100 |
| curcumin | multiple interactions | ISO | RGD:731007 | 6480464 | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:16934760 |
| curcumin | affects expression | ISO | RGD:731007 | 6480464 | Curcumin affects the expression of PTGS2 mRNA | CTD | PMID:18752423 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of PTGS2 protein] | CTD | PMID:18226269 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | [Fluorouracil co-treated with Curcumin] results in decreased expression of PTGS2 protein | CTD | PMID:16340194 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]] | CTD | PMID:17640567 |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 protein | CTD | PMID:17671742 more ... |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin results in decreased expression of PTGS2 mRNA | CTD | PMID:17999991 more ... |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin promotes the reaction [Fluorouracil results in decreased phosphorylation of and results in decreased activity of PTGS2 protein]; more ... | CTD | PMID:17918158 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [VEGFA protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18596194 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of PTGS2 protein] | CTD | PMID:17363495 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [TNFSF11 protein results in increased expression of PTGS2 protein] | CTD | PMID:15129424 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:17640567 more ... |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:16219905 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 protein] | CTD | PMID:17151092 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [Paclitaxel results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16243823 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [Nicotine results in increased expression of PTGS2 protein] | CTD | PMID:20727180 |
| curcumin | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | CTD | PMID:17291458 |
| curcumin | decreases expression | ISO | RGD:731006 | 6480464 | Curcumin analog results in decreased expression of PTGS2 mRNA | CTD | PMID:17671737 PMID:19250217 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PTGS2 mRNA | CTD | PMID:17190766 PMID:18001810 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [VIP protein results in increased expression of PTGS2 protein] | CTD | PMID:17434257 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16804969 PMID:16782535 |
| cyanidin 3-O-beta-D-glucoside | multiple interactions | ISO | RGD:731007 | 6480464 | cyanidin 3-O-glucoside inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PTGS2 protein]; more ... | CTD | PMID:21501596 |
| cycloheximide | multiple interactions | ISO | RGD:731006 | 6480464 | Cycloheximide inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | CTD | PMID:7575673 |
| cycloheximide | multiple interactions | ISO | RGD:731006 | 6480464 | Cycloheximide inhibits the reaction [Dinoprostone promotes the reaction [IL1B protein results in increased expression of PTGS2 protein]]; more ... | CTD | PMID:11112151 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [KNG1 results in increased phosphorylation of PTGS2 protein] | CTD | PMID:16696851 |
| cycloheximide | increases expression | EXP | | 6480464 | Cycloheximide results in increased expression of PTGS2 mRNA | CTD | PMID:11286988 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide promotes the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | CTD | PMID:11286988 |
| cycloheximide | multiple interactions | ISO | RGD:731006 | 6480464 | Cycloheximide inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein] | CTD | PMID:16894348 |
| cyclophosphamide | affects response to substance | ISO | RGD:731006 | 6480464 | PTGS2 protein affects the susceptibility to Cyclophosphamide | CTD | PMID:16217747 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of PTGS2 protein | CTD | PMID:12388444 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of PTGS2 protein | CTD | PMID:12388444 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of PTGS2 protein | CTD | PMID:18514386 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of PTGS2 protein | CTD | PMID:17537839 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of PTGS2 protein | CTD | PMID:17537839 more ... |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | parthenolide inhibits the reaction [Cyclophosphamide results in increased expression of PTGS2 protein] | CTD | PMID:19303104 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of PTGS2 protein | CTD | PMID:19303104 more ... |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of PTGS2 mRNA | CTD | PMID:12388444 |
| cyclophosphamide | increases expression | ISO | RGD:731007 | 6480464 | Cyclophosphamide results in increased expression of PTGS2 mRNA | CTD | PMID:15331540 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | Botulinum Toxins, Type A inhibits the reaction [Cyclophosphamide results in increased expression of PTGS2 protein] | CTD | PMID:18514386 |
| cyclosporin A | multiple interactions | ISO | RGD:731006 | 6480464 | Cyclosporine inhibits the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | CTD | PMID:12493747 |
| cyclosporin A | multiple interactions | ISO | RGD:731007 | 6480464 | Cyclosporine inhibits the reaction [Zymosan results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17312158 |
| D-glucose | multiple interactions | ISO | RGD:731006 | 6480464 | Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19557821 |
| D-glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 protein | CTD | PMID:14514642 more ... |
| D-glucose | multiple interactions | ISO | RGD:731006 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | CTD | PMID:20578705 |
| D-glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 protein | CTD | PMID:14514642 more ... |
| D-glucose | decreases expression | ISO | RGD:731006 | 6480464 | Glucose results in decreased expression of PTGS2 protein | CTD | PMID:21333731 |
| D-glucose | multiple interactions | ISO | RGD:731006 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of PTGS2 protein]] | CTD | PMID:21333731 |
| D-glucose | multiple interactions | ISO | RGD:731007 | 6480464 | [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein; more ... | CTD | PMID:16395278 |
| D-glucose | multiple interactions | ISO | RGD:731006 | 6480464 | carbonyl 3-chlorophenylhydrazone inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:14514642 |
| D-glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 mRNA | CTD | PMID:14514642 more ... |
| D-glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 protein | CTD | PMID:19557821 PMID:14514642 |
| D-glucose | increases expression | ISO | RGD:731007 | 6480464 | Glucose results in increased expression of PTGS2 mRNA | CTD | PMID:17178593 |
| D-glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 mRNA | CTD | PMID:19557821 PMID:19225232 |
| D-glucose | multiple interactions | EXP | | 6480464 | IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19861503 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:19861503 |
| D-glucose | multiple interactions | ISO | RGD:731006 | 6480464 | Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]] | CTD | PMID:19225232 |
| D-glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 protein | CTD | PMID:19557821 |
| D-glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 mRNA | CTD | PMID:19225232 PMID:19557821 |
| daidzein | multiple interactions | ISO | RGD:731006 | 6480464 | [daidzein co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA | CTD | PMID:19347870 |
| daidzein | multiple interactions | ISO | RGD:731006 | 6480464 | daidzein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16870006 |
| daunorubicin | increases expression | EXP | | 6480464 | Daunorubicin results in increased expression of PTGS2 protein | CTD | PMID:20888384 |
| daunorubicin | multiple interactions | EXP | | 6480464 | telmisartan inhibits the reaction [Daunorubicin results in increased expression of PTGS2 protein] | CTD | PMID:20888384 |
| DDD | increases expression | ISO | RGD:731006 | 6480464 | Dichlorodiphenyldichloroethane results in increased expression of PTGS2 protein | CTD | PMID:23132776 |
| DDE | increases expression | ISO | RGD:731006 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of PTGS2 protein | CTD | PMID:19545618 |
| DDE | increases expression | ISO | RGD:731006 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of PTGS2 protein | CTD | PMID:19545618 PMID:23132776 |
| DDT | multiple interactions | ISO | RGD:731006 | 6480464 | zerumbone inhibits the reaction [DDT results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:20865247 |
| DDT | increases expression | ISO | RGD:731006 | 6480464 | DDT results in increased expression of PTGS2 mRNA | CTD | PMID:20865247 |
| dehydroascorbic acid | multiple interactions | EXP | | 6480464 | Dehydroascorbic Acid inhibits the reaction [Blood Glucose affects the expression of PTGS2 protein] | CTD | PMID:15737438 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:731006 | 6480464 | Tetrahydrocannabinol results in increased expression of PTGS2 mRNA | CTD | PMID:11527419 more ... |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:731006 | 6480464 | Tetrahydrocannabinol results in increased expression of PTGS2 protein | CTD | PMID:16330497 |
| Delta(9)-tetrahydrocannabinol | multiple interactions | ISO | RGD:731006 | 6480464 | [Tetrahydrocannabinol results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone | CTD | PMID:11527419 |
| demethoxycurcumin | multiple interactions | ISO | RGD:731007 | 6480464 | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:18449507 |
| deoxycholic acid | increases expression | ISO | RGD:731006 | 6480464 | Deoxycholic Acid results in increased expression of PTGS2 | CTD | PMID:18444174 |
| deoxycholic acid | increases expression | ISO | RGD:731007 | 6480464 | Deoxycholic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:21224055 |
| deoxycholic acid | multiple interactions | ISO | RGD:731006 | 6480464 | NRAS affects the reaction [Deoxycholic Acid results in increased expression of PTGS2]; more ... | CTD | PMID:18444174 |
| desferrioxamine B | increases expression | ISO | RGD:731006 | 6480464 | Deferoxamine results in increased expression of PTGS2 protein; more ... | CTD | PMID:16527254 |
| desferrioxamine B | multiple interactions | ISO | RGD:731007 | 6480464 | ferric citrate inhibits the reaction [Deferoxamine results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16527254 |
| desferrioxamine B | increases expression | ISO | RGD:731007 | 6480464 | Deferoxamine results in increased expression of PTGS2 protein | CTD | PMID:16527254 |
| desferrioxamine B | increases stability | ISO | RGD:731006 | 6480464 | Deferoxamine results in increased stability of PTGS2 protein | CTD | PMID:16527254 |
| desferrioxamine B | multiple interactions | ISO | RGD:731006 | 6480464 | PD 98059 inhibits the reaction [Deferoxamine results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16527254 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [EGF protein results in increased expression of PTGS2 protein] | CTD | PMID:17077316 |
| dexamethasone | decreases expression | ISO | RGD:731006 | 6480464 | Dexamethasone results in decreased expression of PTGS2 mRNA | CTD | PMID:19853017 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | CTD | PMID:20858459 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | CTD | PMID:11112151 PMID:16354411 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [Dinoprostone promotes the reaction [IL1B protein results in increased expression of PTGS2 protein]] | CTD | PMID:11112151 |
| dexamethasone | multiple interactions | ISO | RGD:731007 | 6480464 | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:16880258 PMID:22226038 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [15-deoxyprostaglandin J2 results in increased expression of PTGS2 protein]; more ... | CTD | PMID:12517972 |
| dexamethasone | multiple interactions | ISO | RGD:731007 | 6480464 | Dexamethasone inhibits the reaction [Nickel results in increased expression of PTGS2 mRNA] | CTD | PMID:19839048 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:19255438 PMID:21420233 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of PTGS2 mRNA | CTD | PMID:10588920 PMID:12837037 |
| dexamethasone | multiple interactions | ISO | RGD:731007 | 6480464 | Dexamethasone inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | CTD | PMID:12628480 PMID:11454666 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of PTGS2 protein | CTD | PMID:17562850 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of PTGS2 mRNA | CTD | PMID:12837037 PMID:10588920 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:11099482 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16782535 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:11004044 |
| dexamethasone | multiple interactions | ISO | RGD:731007 | 6480464 | Dexamethasone inhibits the reaction [Zymosan results in increased activity of PTGS2 protein] | CTD | PMID:12604694 |
| dexamethasone | decreases expression | ISO | RGD:731007 | 6480464 | Dexamethasone results in decreased expression of PTGS2 | CTD | PMID:20578217 |
| dexamethasone | multiple interactions | ISO | RGD:731007 | 6480464 | Dexamethasone inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | CTD | PMID:11454666 PMID:12628480 |
| dexamethasone | multiple interactions | ISO | RGD:731007 | 6480464 | Dexamethasone inhibits the reaction [pirinixic acid results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:9013627 |
| dexamethasone | multiple interactions | ISO | RGD:731007 | 6480464 | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16880258 |
| dexamethasone | decreases expression | ISO | RGD:731006 | 6480464 | Dexamethasone results in decreased expression of PTGS2 protein | CTD | PMID:15680906 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | CTD | PMID:7575673 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15489888 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:21420233 PMID:19255438 |
| dexamethasone | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:16354411 |
| dextran sulfate | multiple interactions | ISO | RGD:731007 | 6480464 | [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGS2 mRNA | CTD | PMID:17438113 |
| dextran sulfate | multiple interactions | ISO | RGD:731007 | 6480464 | monotropein inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein] | CTD | PMID:23261679 |
| dextran sulfate | increases expression | ISO | RGD:731007 | 6480464 | Dextran Sulfate results in increased expression of PTGS2 protein | CTD | PMID:16049979 more ... |
| dextran sulfate | increases expression | ISO | RGD:731007 | 6480464 | Dextran Sulfate results in increased expression of PTGS2 protein | CTD | PMID:16049979 more ... |
| dextran sulfate | multiple interactions | ISO | RGD:731007 | 6480464 | [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased expression of PTGS2 protein | CTD | PMID:15459021 |
| dextran sulfate | increases expression | EXP | | 6480464 | Dextran Sulfate results in increased expression of PTGS2 protein | CTD | PMID:19228061 |
| dextran sulfate | multiple interactions | ISO | RGD:731007 | 6480464 | resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA] | CTD | PMID:19940103 |
| dextran sulfate | increases expression | ISO | RGD:731007 | 6480464 | Dextran Sulfate results in increased expression of PTGS2 mRNA | CTD | PMID:15652231 more ... |
| dextran sulfate | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein] | CTD | PMID:19228061 |
| dextran sulfate | increases expression | ISO | RGD:731007 | 6480464 | Dextran Sulfate results in increased expression of PTGS2 protein | CTD | PMID:16049979 PMID:20132809 |
| dextran sulfate | multiple interactions | ISO | RGD:731007 | 6480464 | resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein] | CTD | PMID:20132809 |
| dextran sulfate | increases expression | ISO | RGD:731007 | 6480464 | Dextran Sulfate results in increased expression of PTGS2 mRNA | CTD | PMID:15652231 PMID:20079348 |
| dextran sulfate | increases expression | ISO | RGD:731007 | 6480464 | Dextran Sulfate results in increased expression of PTGS2 mRNA | CTD | PMID:20079348 PMID:15652231 |
| dextran sulfate | multiple interactions | ISO | RGD:731007 | 6480464 | Rutin inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA] | CTD | PMID:15652231 |
| dextran sulfate | increases expression | ISO | RGD:731007 | 6480464 | Dextran Sulfate results in increased expression of PTGS2 mRNA | CTD | PMID:15652231 |
| dextran sulfate | increases expression | ISO | RGD:731007 | 6480464 | Dextran Sulfate results in increased expression of PTGS2 protein | CTD | PMID:16049979 |
| dextromethorphan | multiple interactions | ISO | RGD:731007 | 6480464 | Dextromethorphan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:15987631 |
| diarsenic trioxide | increases expression | ISO | RGD:731006 | 6480464 | arsenic trioxide results in increased expression of PTGS2 mRNA | CTD | PMID:17530438 PMID:18588940 |
| diarsenic trioxide | decreases expression | ISO | RGD:731006 | 6480464 | arsenic trioxide results in decreased expression of PTGS2 mRNA; more ... | CTD | PMID:21540248 |
| diarsenic trioxide | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of PTGS2 mRNA]; more ... | CTD | PMID:21540248 |
| diarsenic trioxide | multiple interactions | ISO | RGD:731007 | 6480464 | [Genistein co-treated with arsenic trioxide] results in decreased expression of PTGS2 protein | CTD | PMID:21078540 |
| diarsenic trioxide | multiple interactions | ISO | RGD:731007 | 6480464 | arsenic trioxide promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:20339114 |
| diarsenic trioxide | multiple interactions | ISO | RGD:731006 | 6480464 | CAT protein inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18588940 |
| diarsenic trioxide | multiple interactions | ISO | RGD:731006 | 6480464 | [Genistein co-treated with arsenic trioxide] results in decreased expression of PTGS2 protein | CTD | PMID:21078540 |
| diarsenic trioxide | increases expression | ISO | RGD:731006 | 6480464 | arsenic trioxide results in increased expression of PTGS2 mRNA | CTD | PMID:18588940 PMID:17530438 |
| diarsenic trioxide | increases expression | ISO | RGD:731006 | 6480464 | arsenic trioxide results in increased expression of PTGS2 protein | CTD | PMID:18588940 |
| diazoxide | multiple interactions | EXP | | 6480464 | BAY 58-2667 inhibits the reaction [Isoproterenol results in increased expression of PTGS2 mRNA] | CTD | PMID:19667237 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 protein | CTD | PMID:18424012 more ... |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 mRNA | CTD | PMID:19667237 PMID:22908232 |
| diazoxide | multiple interactions | EXP | | 6480464 | Doxorubicin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] | CTD | PMID:22908232 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 protein | CTD | PMID:19466570 PMID:18424012 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 mRNA | CTD | PMID:19667237 |
| diazoxide | multiple interactions | EXP | | 6480464 | mangostin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] | CTD | PMID:18424012 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 protein | CTD | PMID:18424012 PMID:19466570 |
| dibenzofuran | increases expression | EXP | | 6480464 | dibenzofuran analog results in increased expression of PTGS2 mRNA | CTD | PMID:20566336 |
| dibenzofuran | multiple interactions | EXP | | 6480464 | AHR protein promotes the reaction [dibenzofuran analog results in increased expression of PTGS2 mRNA] | CTD | PMID:20566336 |
| diclofenac | multiple interactions | ISO | RGD:731006 | 6480464 | Diclofenac inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | CTD | PMID:15705740 |
| diclofenac | decreases activity | EXP | | 6480464 | Diclofenac results in decreased activity of PTGS2 protein | CTD | PMID:9258749 |
| diclofenac | increases expression | ISO | RGD:731006 | 6480464 | Diclofenac results in increased expression of PTGS2 mRNA | CTD | PMID:10594327 |
| diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of PTGS2 protein | CTD | PMID:19031110 |
| diclofenac | increases expression | ISO | RGD:731007 | 6480464 | Diclofenac results in increased expression of PTGS2 protein | CTD | PMID:15626590 |
| diclofenac | decreases activity | ISO | RGD:731007 | 6480464 | Diclofenac results in decreased activity of PTGS2 protein | CTD | PMID:12242329 |
| diclofenac | multiple interactions | ISO | RGD:731007 | 6480464 | Diclofenac binds to and results in decreased activity of PTGS2 protein | CTD | PMID:12925531 |
| diclofenac | multiple interactions | ISO | RGD:731007 | 6480464 | Acetaminophen inhibits the reaction [Diclofenac results in increased expression of PTGS2 protein] | CTD | PMID:15626590 |
| diclofenac | multiple interactions | ISO | RGD:731006 | 6480464 | Diclofenac inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15489888 |
| diclofenac | decreases activity | ISO | RGD:731006 | 6480464 | Diclofenac results in decreased activity of PTGS2 protein | CTD | PMID:17164136 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:731006 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | CTD | PMID:21878375 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of PTGS2 protein | CTD | PMID:12151359 |
| dioxygen | multiple interactions | EXP | | 6480464 | Metoprolol inhibits the reaction [Oxygen deficiency results in increased expression of PTGS2 mRNA] | CTD | PMID:21615343 |
| dioxygen | multiple interactions | ISO | RGD:731006 | 6480464 | Oxygen deficiency promotes the reaction [IL1B protein results in increased expression of PTGS2 protein]; more ... | CTD | PMID:12874281 |
| dioxygen | increases expression | ISO | RGD:731006 | 6480464 | Oxygen deficiency results in increased expression of PTGS2 mRNA | CTD | PMID:20042640 |
| dioxygen | affects expression | EXP | | 6480464 | Oxygen deficiency affects the expression of PTGS2 mRNA | CTD | PMID:17963755 |
| dioxygen | multiple interactions | ISO | RGD:731007 | 6480464 | SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16395278 |
| dioxygen | multiple interactions | ISO | RGD:731006 | 6480464 | HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of PTGS2 mRNA] | CTD | PMID:20042640 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of PTGS2 mRNA | CTD | PMID:21615343 |
| dipyridamole | multiple interactions | ISO | RGD:731007 | 6480464 | Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16765938 |
| dipyridamole | multiple interactions | EXP | | 6480464 | Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20940016 |
| disodium selenite | multiple interactions | ISO | RGD:731007 | 6480464 | Sodium Selenite inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]] | CTD | PMID:18481333 |
| disodium selenite | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PTGS2 mRNA] | CTD | PMID:21705299 |
| disodium selenite | multiple interactions | ISO | RGD:731007 | 6480464 | Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:18279804 PMID:18481333 |
| disodium selenite | multiple interactions | ISO | RGD:731007 | 6480464 | Sodium Selenite inhibits the reaction [Poly I-C results in increased expression of PTGS2 protein] | CTD | PMID:18279804 |
| disodium selenite | multiple interactions | ISO | RGD:731007 | 6480464 | Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:18481333 PMID:18279804 |
| disulfiram | decreases expression | EXP | | 6480464 | Disulfiram results in decreased expression of PTGS2 mRNA | CTD | PMID:10418820 |
| docetaxel anhydrous | increases expression | ISO | RGD:731006 | 6480464 | docetaxel results in increased expression of PTGS2 mRNA | CTD | PMID:15623590 |
| docetaxel anhydrous | increases expression | EXP | | 6480464 | docetaxel results in increased expression of PTGS2 mRNA | CTD | PMID:22902858 |
| doxorubicin | increases expression | ISO | RGD:731006 | 6480464 | Doxorubicin results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:15501994 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] | CTD | PMID:22908232 |
| doxorubicin | increases expression | ISO | RGD:731007 | 6480464 | Doxorubicin results in increased expression of PTGS2 protein | CTD | PMID:17334414 PMID:16449733 |
| doxorubicin | multiple interactions | EXP | | 6480464 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Doxorubicin results in increased activity of PTGS2 protein] | CTD | PMID:11518732 |
| doxorubicin | increases activity | EXP | | 6480464 | Doxorubicin results in increased activity of PTGS2 protein | CTD | PMID:11518732 |
| doxorubicin | affects response to substance | ISO | RGD:731007 | 6480464 | PTGS2 protein affects the susceptibility to Doxorubicin | CTD | PMID:16617129 |
| doxorubicin | multiple interactions | ISO | RGD:731007 | 6480464 | PTGS2 gene mutant form promotes the reaction [Doxorubicin results in increased expression of STK17B mRNA]; more ... | CTD | PMID:16617129 |
| doxorubicin | multiple interactions | ISO | RGD:731007 | 6480464 | EPO protein inhibits the reaction [Doxorubicin results in increased expression of PTGS2 protein] | CTD | PMID:16449733 |
| doxorubicin | increases expression | ISO | RGD:731007 | 6480464 | Doxorubicin results in increased expression of PTGS2 protein | CTD | PMID:16449733 PMID:17334414 |
| doxorubicin | multiple interactions | ISO | RGD:731007 | 6480464 | [Doxorubicin co-treated with PTGS2 protein] results in increased expression of TBXA2R mRNA; more ... | CTD | PMID:19643929 |
| doxorubicin | multiple interactions | ISO | RGD:731007 | 6480464 | CSF3 protein inhibits the reaction [Doxorubicin results in increased expression of PTGS2 protein] | CTD | PMID:17334414 |
| doxorubicin | decreases expression | ISO | RGD:731006 | 6480464 | Doxorubicin results in decreased expression of PTGS2 mRNA | CTD | PMID:15205334 |
| doxorubicin | decreases response to substance | ISO | RGD:731006 | 6480464 | PTGS2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:18498876 |
| elemental selenium | multiple interactions | ISO | RGD:731007 | 6480464 | PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein]] | CTD | PMID:17439952 |
| elemental selenium | multiple interactions | ISO | RGD:731007 | 6480464 | Selenium deficiency promotes the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; more ... | CTD | PMID:11978490 |
| enalapril | decreases expression | EXP | | 6480464 | Enalapril results in decreased expression of PTGS2 protein | CTD | PMID:21377515 |
| enalapril | multiple interactions | ISO | RGD:731007 | 6480464 | [paricalcitol co-treated with Enalapril] results in decreased expression of PTGS2 protein | CTD | PMID:20720404 |
| enalapril | decreases expression | ISO | RGD:731007 | 6480464 | Enalapril results in decreased expression of PTGS2 protein | CTD | PMID:20720404 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of PTGS2 mRNA | CTD | PMID:17067360 |
| ethanol | multiple interactions | ISO | RGD:731006 | 6480464 | [sodium arsenite co-treated with Ethanol] results in increased expression of PTGS2 protein | CTD | PMID:22872060 |
| ethanol | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Ethanol results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:22525864 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of PTGS2 mRNA | CTD | PMID:17067360 PMID:22525864 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of PTGS2 protein | CTD | PMID:22525864 |
| ethanol | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with Fish Oils] results in increased expression of PTGS2 protein; more ... | CTD | PMID:15016835 |
| ethanol | multiple interactions | ISO | RGD:731007 | 6480464 | [Ethanol co-treated with Thioacetamide] results in increased expression of PTGS2 mRNA | CTD | PMID:21863215 |
| ethanol | multiple interactions | EXP | | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Ethanol results in increased expression of PTGS2 mRNA] | CTD | PMID:17067360 |
| ethylbenzene | multiple interactions | ISO | RGD:731007 | 6480464 | [S-8 fuel co-treated with Benzene co-treated with Toluene co-treated with ethylbenzene co-treated with Xylenes co-treated with pseudocumene co-treated with Naphthalenes co-treated with phenylcyclohexane] results in increased expression of PTGS2 mRNA | CTD | PMID:17890764 |
| etodolac | multiple interactions | ISO | RGD:731006 | 6480464 | Etodolac inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | CTD | PMID:16004971 |
| etodolac | increases expression | ISO | RGD:731006 | 6480464 | Etodolac results in increased expression of PTGS2 mRNA | CTD | PMID:10594327 |
| etodolac | decreases activity | EXP | | 6480464 | Etodolac results in decreased activity of PTGS2 protein | CTD | PMID:16979129 |
| etodolac | decreases expression | ISO | RGD:731007 | 6480464 | Etodolac results in decreased expression of PTGS2 mRNA | CTD | PMID:16391837 |
| etodolac | multiple interactions | ISO | RGD:731006 | 6480464 | [Etodolac results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone | CTD | PMID:12417326 |
| etodolac | decreases activity | ISO | RGD:731006 | 6480464 | Etodolac results in decreased activity of PTGS2 protein | CTD | PMID:16004971 |
| etoricoxib | decreases activity | ISO | RGD:731006 | 6480464 | etoricoxib results in decreased activity of PTGS2 protein | CTD | PMID:17164136 |
| etoricoxib | decreases activity | ISO | RGD:731006 | 6480464 | etoricoxib results in decreased activity of PTGS2 protein mutant form | CTD | PMID:22245433 |
| etoricoxib | decreases activity | ISO | RGD:731006 | 6480464 | etoricoxib results in decreased activity of PTGS2 protein | CTD | PMID:17164136 PMID:22245433 |
| etoricoxib | multiple interactions | EXP | | 6480464 | etoricoxib inhibits the reaction [Ifosfamide results in increased expression of PTGS2 protein] | CTD | PMID:17638016 |
| eugenol | multiple interactions | ISO | RGD:731006 | 6480464 | Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:17509409 |
| eugenol | multiple interactions | ISO | RGD:731006 | 6480464 | Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; more ... | CTD | PMID:21807015 |
| eugenol | multiple interactions | ISO | RGD:731007 | 6480464 | Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:12757841 PMID:16101137 |
| eugenol | decreases expression | ISO | RGD:731006 | 6480464 | Eugenol results in decreased expression of PTGS2 mRNA | CTD | PMID:21939359 PMID:12757841 |
| eugenol | multiple interactions | ISO | RGD:731007 | 6480464 | Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:16101137 PMID:12757841 |
| eugenol | multiple interactions | ISO | RGD:731007 | 6480464 | Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; more ... | CTD | PMID:12757841 |
| eugenol | decreases expression | ISO | RGD:731006 | 6480464 | Eugenol results in decreased expression of PTGS2 mRNA | CTD | PMID:12757841 PMID:21939359 |
| eugenol | multiple interactions | EXP | | 6480464 | Eugenol inhibits the reaction [Thioacetamide results in increased expression of PTGS2]; more ... | CTD | PMID:20036707 |
| eugenol | decreases expression | ISO | RGD:731006 | 6480464 | Eugenol results in decreased expression of PTGS2 mRNA | CTD | PMID:21939359 |
| eugenol | multiple interactions | ISO | RGD:731007 | 6480464 | Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20043298 |
| eupatilin | multiple interactions | ISO | RGD:731007 | 6480464 | eupatilin inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21565208 |
| everolimus | increases expression | EXP | | 6480464 | everolimus results in increased expression of PTGS2 protein; more ... | CTD | PMID:15937522 |
| fenofibrate | multiple interactions | ISO | RGD:731007 | 6480464 | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:21300114 |
| ferulic acid | decreases expression | ISO | RGD:731006 | 6480464 | ferulic acid results in decreased expression of PTGS2 protein | CTD | PMID:15841493 |
| ferulic acid | multiple interactions | ISO | RGD:731007 | 6480464 | ferulic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21291945 |
| ferulic acid | multiple interactions | EXP | | 6480464 | ferulic acid inhibits the reaction [Nicotine results in increased expression of PTGS2 protein] | CTD | PMID:18068289 |
| ferulic acid | multiple interactions | ISO | RGD:731007 | 6480464 | ferulic acid analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:17436566 |
| flufenamic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:10866999 |
| flufenamic acid | increases expression | ISO | RGD:731006 | 6480464 | Flufenamic Acid results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:10866999 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of PTGS2 mRNA | CTD | PMID:21966942 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of PTGS2 mRNA | CTD | PMID:17033635 PMID:21966942 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of PTGS2 protein | CTD | PMID:21554931 |
| flupenthixol | decreases expression | ISO | RGD:731006 | 6480464 | Flupenthixol results in decreased expression of PTGS2 protein | CTD | PMID:8897462 |
| flurbiprofen | multiple interactions | EXP | | 6480464 | Flurbiprofen inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:11099482 |
| flurbiprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone] | CTD | PMID:11095985 |
| flurbiprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Flurbiprofen inhibits the reaction [16,16-Dimethylprostaglandin E2 results in increased expression of PTGS2 mRNA] | CTD | PMID:9099957 |
| flurbiprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Flurbiprofen inhibits the reaction [[IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; more ... | CTD | PMID:11112151 |
| flurbiprofen | decreases activity | EXP | | 6480464 | Flurbiprofen results in decreased activity of PTGS2 protein | CTD | PMID:9258749 |
| flurbiprofen | multiple interactions | ISO | RGD:731007 | 6480464 | Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone] | CTD | PMID:11405284 |
| flurbiprofen | increases expression | ISO | RGD:731006 | 6480464 | Flurbiprofen results in increased expression of PTGS2 mRNA | CTD | PMID:10594327 PMID:12517972 |
| flurbiprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Flurbiprofen inhibits the reaction [Dinoprostone results in increased expression of PTGS2 mRNA] | CTD | PMID:9321948 |
| flurbiprofen | decreases degradation | ISO | RGD:731007 | 6480464 | Flurbiprofen results in decreased degradation of PTGS2 protein; more ... | CTD | PMID:19758985 |
| flurbiprofen | decreases activity | ISO | RGD:731006 | 6480464 | Flurbiprofen results in decreased activity of PTGS2 protein mutant form | CTD | PMID:22245433 |
| flurbiprofen | decreases activity | ISO | RGD:731006 | 6480464 | Flurbiprofen results in decreased activity of PTGS2 protein | CTD | PMID:18848576 PMID:22245433 |
| flurbiprofen | increases expression | ISO | RGD:731006 | 6480464 | Flurbiprofen results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:12517972 |
| flurbiprofen | increases expression | ISO | RGD:731006 | 6480464 | Flurbiprofen results in increased expression of PTGS2 protein | CTD | PMID:11687965 |
| flurbiprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Flurbiprofen promotes the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:12517972 |
| flurbiprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Flurbiprofen inhibits the reaction [Arachidonic Acid results in increased expression of PTGS2 mRNA] | CTD | PMID:15878913 |
| flurbiprofen | decreases activity | ISO | RGD:731006 | 6480464 | Flurbiprofen results in decreased activity of PTGS2 protein | CTD | PMID:18848576 |
| flurbiprofen | decreases expression | ISO | RGD:731007 | 6480464 | Flurbiprofen results in decreased expression of PTGS2 mRNA | CTD | PMID:16949054 |
| formaldehyde | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [[Formaldehyde co-treated with eugenol, zinc oxide dental cavity lining] results in increased expression of PTGS2 mRNA] | CTD | PMID:15934011 |
| formaldehyde | increases expression | ISO | RGD:731006 | 6480464 | Formaldehyde results in increased expression of PTGS2 mRNA | CTD | PMID:20655997 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of PTGS2 mRNA | CTD | PMID:14757778 |
| fucoxanthin | multiple interactions | ISO | RGD:731007 | 6480464 | fucoxanthin analog affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:22735499 |
| fulvestrant | multiple interactions | ISO | RGD:731007 | 6480464 | fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]] | CTD | PMID:15256495 |
| fulvestrant | multiple interactions | ISO | RGD:731006 | 6480464 | fulvestrant promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PTGS2 mRNA] | CTD | PMID:21513769 |
| fulvestrant | multiple interactions | ISO | RGD:731006 | 6480464 | fulvestrant inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of PTGS2 protein] | CTD | PMID:20951759 |
| furosemide | affects expression | EXP | | 6480464 | Furosemide affects the expression of PTGS2 protein; more ... | CTD | PMID:11961000 |
| furosemide | increases expression | EXP | | 6480464 | Furosemide results in increased expression of PTGS2 protein | CTD | PMID:11135058 PMID:19031110 |
| furosemide | increases expression | EXP | | 6480464 | Furosemide results in increased expression of PTGS2 mRNA | CTD | PMID:11703585 PMID:11135058 |
| furosemide | increases expression | EXP | | 6480464 | Furosemide results in increased expression of PTGS2 protein | CTD | PMID:19031110 PMID:11135058 |
| furosemide | multiple interactions | EXP | | 6480464 | [Furosemide results in increased expression of PTGS2 mRNA] which results in increased abundance of Prostaglandins; more ... | CTD | PMID:11703585 |
| furosemide | increases expression | EXP | | 6480464 | Furosemide results in increased expression of PTGS2 mRNA | CTD | PMID:11135058 PMID:11703585 |
| galactose | multiple interactions | ISO | RGD:731007 | 6480464 | Galactose results in increased expression of and results in increased activity of PTGS2 protein; more ... | CTD | PMID:22687555 |
| galactose | increases expression | ISO | RGD:731007 | 6480464 | Galactose results in increased expression of PTGS2 mRNA | CTD | PMID:22687555 |
| gallic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Gallic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:21420233 |
| gallic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Gallic Acid promotes the reaction [imatinib results in decreased expression of PTGS2 protein]; more ... | CTD | PMID:22245431 |
| gallic acid | decreases expression | ISO | RGD:731006 | 6480464 | Gallic Acid results in decreased expression of PTGS2 protein | CTD | PMID:22245431 |
| gamma-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | Lindane results in increased expression of and results in increased activity of PTGS2 protein | CTD | PMID:10426785 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:10426785 |
| gamma-linolenic acid | increases expression | ISO | RGD:731006 | 6480464 | gamma-Linolenic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:17092368 |
| gefitinib | multiple interactions | ISO | RGD:731006 | 6480464 | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein] | CTD | PMID:16322342 |
| geldanamycin | multiple interactions | EXP | | 6480464 | geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]]; more ... | CTD | PMID:11133817 |
| genistein | multiple interactions | ISO | RGD:731007 | 6480464 | [Genistein co-treated with arsenic trioxide] results in decreased expression of PTGS2 protein | CTD | PMID:21078540 |
| genistein | multiple interactions | ISO | RGD:731007 | 6480464 | Genistein inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:9576062 PMID:9580637 |
| genistein | decreases expression | ISO | RGD:731006 | 6480464 | Genistein results in decreased expression of PTGS2 protein | CTD | PMID:19723084 PMID:21078540 |
| genistein | multiple interactions | ISO | RGD:731007 | 6480464 | Genistein inhibits the reaction [Calcium, Dietary affects the expression of PTGS2 protein] | CTD | PMID:17182828 |
| genistein | multiple interactions | ISO | RGD:731006 | 6480464 | Genistein inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] | CTD | PMID:10783318 |
| genistein | multiple interactions | ISO | RGD:731006 | 6480464 | Genistein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16870006 |
| genistein | multiple interactions | ISO | RGD:731006 | 6480464 | [Genistein inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein]] which results in decreased abundance of Dinoprostone | CTD | PMID:15896711 |
| genistein | multiple interactions | ISO | RGD:731006 | 6480464 | [Genistein co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA | CTD | PMID:19347870 |
| genistein | multiple interactions | ISO | RGD:731006 | 6480464 | [Genistein co-treated with arsenic trioxide] results in decreased expression of PTGS2 protein | CTD | PMID:21078540 |
| genistein | multiple interactions | ISO | RGD:731006 | 6480464 | Capsaicin promotes the reaction [Genistein results in decreased expression of PTGS2 protein] | CTD | PMID:19723084 |
| genistein | decreases expression | ISO | RGD:731007 | 6480464 | Genistein results in decreased expression of PTGS2 protein | CTD | PMID:21078540 |
| genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Capsaicin] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]; more ... | CTD | PMID:19723084 |
| genistein | multiple interactions | ISO | RGD:731007 | 6480464 | Genistein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:19063610 |
| genistein | decreases expression | ISO | RGD:731006 | 6480464 | Genistein results in decreased expression of PTGS2 protein | CTD | PMID:21078540 PMID:19723084 |
| genistein | decreases expression | ISO | RGD:731006 | 6480464 | Genistein results in decreased expression of PTGS2 mRNA | CTD | PMID:10783318 |
| glucose | multiple interactions | ISO | RGD:731006 | 6480464 | Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19557821 |
| glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 protein | CTD | PMID:14514642 more ... |
| glucose | multiple interactions | ISO | RGD:731006 | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | CTD | PMID:20578705 |
| glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 protein | CTD | PMID:14514642 more ... |
| glucose | decreases expression | ISO | RGD:731006 | 6480464 | Glucose results in decreased expression of PTGS2 protein | CTD | PMID:21333731 |
| glucose | multiple interactions | ISO | RGD:731006 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of PTGS2 protein]] | CTD | PMID:21333731 |
| glucose | multiple interactions | ISO | RGD:731007 | 6480464 | [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein; more ... | CTD | PMID:16395278 |
| glucose | multiple interactions | ISO | RGD:731006 | 6480464 | carbonyl 3-chlorophenylhydrazone inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:14514642 |
| glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 mRNA | CTD | PMID:14514642 more ... |
| glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 protein | CTD | PMID:19557821 PMID:14514642 |
| glucose | increases expression | ISO | RGD:731007 | 6480464 | Glucose results in increased expression of PTGS2 mRNA | CTD | PMID:17178593 |
| glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 mRNA | CTD | PMID:19557821 PMID:19225232 |
| glucose | multiple interactions | EXP | | 6480464 | IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19861503 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:19861503 |
| glucose | multiple interactions | ISO | RGD:731006 | 6480464 | Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]] | CTD | PMID:19225232 |
| glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 protein | CTD | PMID:19557821 |
| glucose | increases expression | ISO | RGD:731006 | 6480464 | Glucose results in increased expression of PTGS2 mRNA | CTD | PMID:19225232 PMID:19557821 |
| glutathione | multiple interactions | ISO | RGD:731006 | 6480464 | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]] | CTD | PMID:17640567 |
| glutathione | multiple interactions | ISO | RGD:731007 | 6480464 | Glutathione inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of PTGS2 protein] | CTD | PMID:21722719 |
| glycyrrhetinate | multiple interactions | ISO | RGD:731007 | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21644799 |
| glycyrrhetinic acid | multiple interactions | ISO | RGD:731007 | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21644799 |
| glycyrrhizinic acid | multiple interactions | ISO | RGD:731007 | 6480464 | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:17917259 |
| glycyrrhizinic acid | multiple interactions | ISO | RGD:731007 | 6480464 | Glycyrrhizic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21644799 |
| Goe 6976 | multiple interactions | EXP | | 6480464 | Go 6976 inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | CTD | PMID:15210717 |
| Goe 6976 | multiple interactions | ISO | RGD:731006 | 6480464 | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | CTD | PMID:19804834 |
| Goe 6976 | multiple interactions | ISO | RGD:731006 | 6480464 | Go 6976 inhibits the reaction [PLD2 protein promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein]]; more ... | CTD | PMID:15210717 |
| gold atom | multiple interactions | ISO | RGD:731007 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased expression of PTGS2 mRNA | CTD | PMID:22155353 |
| gold atom | increases expression | ISO | RGD:731007 | 6480464 | Gold results in increased expression of PTGS2 mRNA | CTD | PMID:22155353 |
| gold(0) | multiple interactions | ISO | RGD:731007 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased expression of PTGS2 mRNA | CTD | PMID:22155353 |
| gold(0) | increases expression | ISO | RGD:731007 | 6480464 | Gold results in increased expression of PTGS2 mRNA | CTD | PMID:22155353 |
| guaiacol | multiple interactions | ISO | RGD:731007 | 6480464 | Guaiacol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; more ... | CTD | PMID:17465205 |
| halothane | multiple interactions | EXP | | 6480464 | Halothane inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | CTD | PMID:11506125 |
| heparin | multiple interactions | EXP | | 6480464 | Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of PTGS2 mRNA] | CTD | PMID:16401727 |
| herbimycin | multiple interactions | EXP | | 6480464 | herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:11133817 |
| herbimycin | decreases expression | EXP | | 6480464 | herbimycin results in decreased expression of PTGS2 mRNA | CTD | PMID:11133817 |
| hesperetin | multiple interactions | ISO | RGD:731007 | 6480464 | hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:16101151 |
| hesperetin | affects activity | EXP | | 6480464 | hesperetin affects the activity of PTGS2 protein | CTD | PMID:15240993 |
| hesperidin | multiple interactions | ISO | RGD:731007 | 6480464 | Hesperidin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:16101151 |
| hesperidin | multiple interactions | ISO | RGD:731006 | 6480464 | Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of PTGS2 mRNA] | CTD | PMID:19110045 |
| histamine | multiple interactions | ISO | RGD:731006 | 6480464 | Histamine promotes the reaction [TLR2 results in increased expression of PTGS2]; more ... | CTD | PMID:20040740 |
| hydrogen chloride | multiple interactions | ISO | RGD:731007 | 6480464 | [Aspirin co-treated with Hydrochloric Acid] results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:15236176 |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of PTGS2 protein; more ... | CTD | PMID:15309881 PMID:12853844 |
| hydrogen chloride | increases expression | EXP | | 6480464 | Hydrochloric Acid results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:12853844 PMID:15309881 |
| hydrogen chloride | multiple interactions | EXP | | 6480464 | [Hydrochloric Acid co-treated with Piroxicam] results in increased expression of PTGS2 mRNA | CTD | PMID:15309881 |
| hydrogen chloride | multiple interactions | EXP | | 6480464 | [Aspirin co-treated with Hydrochloric Acid] results in increased expression of PTGS2 mRNA | CTD | PMID:9726391 |
| hydrogen peroxide | increases activity | ISO | RGD:731006 | 6480464 | Hydrogen Peroxide results in increased activity of PTGS2 protein | CTD | PMID:10491155 |
| hydrogen peroxide | multiple interactions | ISO | RGD:731007 | 6480464 | resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of PTGS2 protein] | CTD | PMID:10718345 |
| hydrogen peroxide | increases expression | ISO | RGD:731007 | 6480464 | Hydrogen Peroxide results in increased expression of PTGS2 protein | CTD | PMID:10718345 PMID:20335659 |
| hydrogen peroxide | multiple interactions | ISO | RGD:731007 | 6480464 | Hydrogen Peroxide affects the reaction [Sodium Salicylate results in decreased activity of PTGS2 protein] | CTD | PMID:12538810 |
| hydrogen peroxide | multiple interactions | ISO | RGD:731006 | 6480464 | Calcimycin promotes the reaction [[Hydrogen Peroxide co-treated with Vanadates] results in increased expression of PTGS2 mRNA alternative form] | CTD | PMID:10837497 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of PTGS2 protein | CTD | PMID:22081883 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | calycopterin results in decreased susceptibility to [Hydrogen Peroxide results in increased expression of PTGS2 protein] | CTD | PMID:22081883 |
| hydrogen peroxide | increases activity | EXP | | 6480464 | Hydrogen Peroxide results in increased activity of PTGS2 protein | CTD | PMID:15604817 |
| hydrogen peroxide | multiple interactions | ISO | RGD:731007 | 6480464 | SIRT1 mutant form inhibits the reaction [Hydrogen Peroxide results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:20335659 |
| hydrogen peroxide | increases expression | ISO | RGD:731007 | 6480464 | Hydrogen Peroxide results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:20335659 |
| hydrogen peroxide | multiple interactions | ISO | RGD:731006 | 6480464 | [Hydrogen Peroxide results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone; more ... | CTD | PMID:10491155 |
| hydroxytyrosol | multiple interactions | ISO | RGD:731006 | 6480464 | 3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:22595400 |
| ibuprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Ibuprofen inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15489888 |
| ibuprofen | decreases degradation | ISO | RGD:731007 | 6480464 | Ibuprofen results in decreased degradation of PTGS2 protein | CTD | PMID:19758985 |
| ibuprofen | decreases activity | ISO | RGD:731006 | 6480464 | Ibuprofen results in decreased activity of PTGS2 protein mutant form | CTD | PMID:22245433 |
| ibuprofen | decreases activity | ISO | RGD:731006 | 6480464 | Ibuprofen results in decreased activity of PTGS2 protein | CTD | PMID:17164136 more ... |
| ibuprofen | decreases expression | EXP | | 6480464 | Ibuprofen results in decreased expression of PTGS2 mRNA | CTD | PMID:10697514 PMID:16249722 |
| ibuprofen | decreases activity | ISO | RGD:731006 | 6480464 | Ibuprofen results in decreased activity of PTGS2 protein | CTD | PMID:17164136 PMID:18848576 |
| ibuprofen | decreases activity | ISO | RGD:731006 | 6480464 | Ibuprofen results in decreased activity of PTGS2 protein | CTD | PMID:18848576 PMID:17164136 |
| ibuprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Ibuprofen inhibits the reaction [PTGS2 protein affects the chemical synthesis of and affects the abundance of Dinoprostone]; more ... | CTD | PMID:18297109 |
| ibuprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]; more ... | CTD | PMID:15705740 |
| ibuprofen | decreases expression | EXP | | 6480464 | Ibuprofen results in decreased expression of PTGS2 mRNA | CTD | PMID:16249722 PMID:10697514 |
| ibuprofen | increases expression | EXP | | 6480464 | Ibuprofen results in increased expression of PTGS2 mRNA | CTD | PMID:18096423 |
| ibuprofen | multiple interactions | EXP | | 6480464 | Ibuprofen inhibits the reaction [endotoxin, Escherichia coli promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]]; more ... | CTD | PMID:16997862 |
| ibuprofen | decreases expression | ISO | RGD:731007 | 6480464 | Ibuprofen results in decreased expression of PTGS2 mRNA | CTD | PMID:15817521 |
| ibuprofen | decreases activity | ISO | RGD:731007 | 6480464 | Ibuprofen results in decreased activity of PTGS2 protein | CTD | PMID:12242329 |
| ibuprofen | increases response to substance | ISO | RGD:731006 | 6480464 | PTGS2 gene SNP results in increased susceptibility to Ibuprofen | CTD | PMID:16678543 |
| ibuprofen | increases expression | ISO | RGD:731006 | 6480464 | Ibuprofen results in increased expression of PTGS2 mRNA | CTD | PMID:16678543 |
| icatibant | multiple interactions | EXP | | 6480464 | icatibant inhibits the reaction [KNG1 results in increased expression of PTGS2 mRNA] | CTD | PMID:15750287 |
| ifosfamide | multiple interactions | EXP | | 6480464 | etoricoxib inhibits the reaction [Ifosfamide results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17638016 |
| ifosfamide | increases expression | EXP | | 6480464 | Ifosfamide results in increased expression of PTGS2 protein | CTD | PMID:17638016 |
| iloprost | multiple interactions | ISO | RGD:731007 | 6480464 | Iloprost inhibits the reaction [PTGS2 gene mutant form promotes the reaction [Doxorubicin results in increased expression of STK17B mRNA]] | CTD | PMID:16617129 |
| imatinib | multiple interactions | ISO | RGD:731006 | 6480464 | Gallic Acid promotes the reaction [imatinib results in decreased expression of PTGS2 protein]; more ... | CTD | PMID:22245431 |
| imatinib | decreases expression | ISO | RGD:731006 | 6480464 | imatinib results in decreased expression of PTGS2 protein | CTD | PMID:22245431 |
| indole-3-methanol | multiple interactions | ISO | RGD:731006 | 6480464 | indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15811958 |
| indomethacin | decreases activity | ISO | RGD:731006 | 6480464 | Indomethacin results in decreased activity of PTGS2 protein | CTD | PMID:12517972 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:11321505 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | butaprost inhibits the reaction [[Indomethacin results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein]; more ... | CTD | PMID:21268125 |
| indomethacin | decreases activity | ISO | RGD:731007 | 6480464 | Indomethacin results in decreased activity of PTGS2 protein | CTD | PMID:12242329 PMID:21268125 |
| indomethacin | decreases activity | EXP | | 6480464 | Indomethacin results in decreased activity of PTGS2 protein | CTD | PMID:9258749 |
| indomethacin | increases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in increased expression of PTGS2 mRNA | CTD | PMID:10594327 PMID:12517972 |
| indomethacin | increases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in increased expression of [IL1B protein results in increased expression of PTGS2 protein]; more ... | CTD | PMID:12517972 |
| indomethacin | decreases activity | ISO | RGD:731006 | 6480464 | Indomethacin results in decreased activity of PTGS2 protein | CTD | PMID:12517972 PMID:16190777 |
| indomethacin | multiple interactions | ISO | RGD:731006 | 6480464 | Indomethacin promotes the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | CTD | PMID:12517972 |
| indomethacin | multiple interactions | ISO | RGD:731006 | 6480464 | Indomethacin inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | CTD | PMID:12517972 PMID:15705740 |
| indomethacin | increases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in increased expression of PTGS2 protein | CTD | PMID:10866999 more ... |
| indomethacin | decreases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:10866311 more ... |
| indomethacin | decreases expression | ISO | RGD:731007 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:17329845 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PTGS2 mRNA | CTD | PMID:15104355 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PTGS2 mRNA | CTD | PMID:16080005 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of PTGS2 protein | CTD | PMID:16818512 PMID:20361948 |
| indomethacin | decreases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:11504793 more ... |
| indomethacin | decreases expression | ISO | RGD:731007 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:18237397 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PTGS2 mRNA | CTD | PMID:15831440 more ... |
| indomethacin | decreases expression | ISO | RGD:731007 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:18237397 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PTGS2 | CTD | PMID:16259740 PMID:16804302 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PTGS2 mRNA | CTD | PMID:15996031 more ... |
| indomethacin | decreases expression | ISO | RGD:731007 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:18431645 more ... |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PTGS2 mRNA | CTD | PMID:16699067 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of PTGS2 protein | CTD | PMID:20361948 PMID:16818512 |
| indomethacin | decreases expression | ISO | RGD:731007 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:17329845 more ... |
| indomethacin | increases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in increased expression of PTGS2 protein | CTD | PMID:15482327 PMID:10866999 |
| indomethacin | decreases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:10866311 PMID:11504793 |
| indomethacin | decreases activity | ISO | RGD:731006 | 6480464 | Indomethacin analog results in decreased activity of PTGS2 protein | CTD | PMID:12142058 PMID:16690318 |
| indomethacin | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased expression of PTGS2 mRNA] | CTD | PMID:15104355 |
| indomethacin | multiple interactions | EXP | | 6480464 | Atropine inhibits the reaction [Indomethacin results in increased expression of PTGS2]; more ... | CTD | PMID:16804302 |
| indomethacin | multiple interactions | EXP | | 6480464 | Atropine affects the reaction [Indomethacin results in increased expression of PTGS2] | CTD | PMID:16259740 |
| indomethacin | multiple interactions | EXP | | 6480464 | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased activity of PTGS2 protein]; more ... | CTD | PMID:16818512 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | Plant Extracts inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | CTD | PMID:18237397 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | oren gedoku to inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | CTD | PMID:17329845 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | malabaricone B inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein]; more ... | CTD | PMID:17977527 |
| indomethacin | decreases expression | ISO | RGD:731007 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:18431645 more ... |
| indomethacin | increases expression | ISO | RGD:731007 | 6480464 | Indomethacin results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:9013627 |
| indomethacin | decreases activity | ISO | RGD:731007 | 6480464 | Indomethacin results in decreased activity of PTGS2 protein | CTD | PMID:12242329 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | Indomethacin promotes the reaction [deoxynivalenol results in increased expression of PTGS2 protein] | CTD | PMID:12377986 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | Indomethacin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of PTGS2 protein] | CTD | PMID:18617548 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | Indomethacin inhibits the reaction [[soluble tachyzoite antigen, Toxoplasma gondii results in increased expression of PTGS2 mRNA] which results in increased abundance of Dinoprostone]; more ... | CTD | PMID:18305957 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | Indomethacin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21513785 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | Indomethacin inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:22107987 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | Indomethacin analog binds to and results in decreased activity of PTGS2 protein | CTD | PMID:12135387 |
| indomethacin | multiple interactions | ISO | RGD:731007 | 6480464 | allylpyrocatechol inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | CTD | PMID:18431645 |
| indomethacin | increases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in increased expression of PTGS2 protein | CTD | PMID:10866999 PMID:15482327 |
| indomethacin | increases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in increased expression of PTGS2 | CTD | PMID:11840453 |
| indomethacin | decreases expression | ISO | RGD:731006 | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:11504793 PMID:10866311 |
| indomethacin | decreases activity | ISO | RGD:731006 | 6480464 | Indomethacin results in decreased activity of PTGS2 protein | CTD | PMID:16190777 |
| indomethacin | multiple interactions | ISO | RGD:731006 | 6480464 | Indomethacin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15489888 |
| indomethacin | multiple interactions | ISO | RGD:731006 | 6480464 | Indomethacin inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | CTD | PMID:15705740 |
| indomethacin | decreases activity | ISO | RGD:731006 | 6480464 | Indomethacin analog results in decreased activity of PTGS2 protein | CTD | PMID:16690318 PMID:12142058 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PTGS2 protein | CTD | PMID:12428691 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PTGS2 mRNA | CTD | PMID:16699067 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of PTGS2 protein | CTD | PMID:16818512 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of PTGS2 | CTD | PMID:16804302 PMID:16259740 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of PTGS2 protein | CTD | PMID:15067210 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of PTGS2 mRNA | CTD | PMID:18096423 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Misoprostol results in increased expression of PTGS2 protein] | CTD | PMID:12428691 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Ifosfamide results in increased expression of PTGS2 protein] | CTD | PMID:17638016 |
| indomethacin | affects expression | EXP | | 6480464 | Indomethacin affects the expression of PTGS2 protein | CTD | PMID:9502396 |
| iron atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of PTGS2 protein | CTD | PMID:20302851 |
| isoflurane | increases expression | EXP | | 6480464 | Isoflurane results in increased expression of PTGS2 mRNA | CTD | PMID:21615343 |
| isoflurane | multiple interactions | EXP | | 6480464 | Metoprolol inhibits the reaction [Isoflurane results in increased expression of PTGS2 mRNA] | CTD | PMID:21615343 |
| isoliquiritigenin | multiple interactions | ISO | RGD:731007 | 6480464 | isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18295200 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 mRNA | CTD | PMID:19667237 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 protein | CTD | PMID:18424012 more ... |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 mRNA | CTD | PMID:19667237 PMID:22908232 |
| isoprenaline | multiple interactions | EXP | | 6480464 | Doxorubicin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] | CTD | PMID:22908232 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 protein | CTD | PMID:18424012 PMID:19466570 |
| isoprenaline | multiple interactions | EXP | | 6480464 | mangostin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] | CTD | PMID:18424012 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PTGS2 protein | CTD | PMID:19466570 PMID:18424012 |
| isoprenaline | multiple interactions | EXP | | 6480464 | BAY 58-2667 inhibits the reaction [Isoproterenol results in increased expression of PTGS2 mRNA] | CTD | PMID:19667237 |
| isotretinoin | decreases expression | ISO | RGD:731006 | 6480464 | Isotretinoin results in decreased expression of PTGS2 mRNA | CTD | PMID:15982314 |
| ivermectin | multiple interactions | ISO | RGD:731007 | 6480464 | Ivermectin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]; more ... | CTD | PMID:19168156 |
| kaempferol | multiple interactions | ISO | RGD:731006 | 6480464 | kaempferol inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] | CTD | PMID:10783318 |
| kaempferol | decreases expression | ISO | RGD:731006 | 6480464 | kaempferol results in decreased expression of PTGS2 mRNA | CTD | PMID:10783318 PMID:17184768 |
| kaempferol | multiple interactions | ISO | RGD:731007 | 6480464 | PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | CTD | PMID:11343698 |
| kaempferol | multiple interactions | ISO | RGD:731007 | 6480464 | kaempferol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | CTD | PMID:19352036 |
| kaempferol | decreases expression | ISO | RGD:731006 | 6480464 | kaempferol results in decreased expression of PTGS2 protein | CTD | PMID:17184768 |
| kaempferol | decreases expression | ISO | RGD:731006 | 6480464 | kaempferol results in decreased expression of PTGS2 mRNA | CTD | PMID:17184768 PMID:10783318 |
| kaempferol 3-O-glucoside | multiple interactions | ISO | RGD:731007 | 6480464 | astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:22210036 |
| kainic acid | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:17827730 |
| kainic acid | multiple interactions | ISO | RGD:731007 | 6480464 | PTGS2 protein inhibits the reaction [Kainic Acid results in decreased expression of GRIA1 mRNA]; more ... | CTD | PMID:21589914 |
| kainic acid | decreases response to substance | ISO | RGD:731007 | 6480464 | PTGS2 protein results in decreased susceptibility to Kainic Acid | CTD | PMID:21589914 |
| kainic acid | increases response to substance | ISO | RGD:731007 | 6480464 | PTGS2 gene mutant form results in increased susceptibility to Kainic Acid | CTD | PMID:18834901 |
| kainic acid | multiple interactions | ISO | RGD:731007 | 6480464 | [PTGS2 gene mutant form results in increased susceptibility to Kainic Acid] which results in increased abundance of Prostaglandin D2; more ... | CTD | PMID:18834901 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:11168565 more ... |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:17827730 PMID:11168565 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:11168565 PMID:17827730 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of PTGS2 | CTD | PMID:12618123 |
| ketoprofen | multiple interactions | ISO | RGD:731006 | 6480464 | Ketoprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone] | CTD | PMID:11095985 |
| L-ascorbic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Ascorbic Acid inhibits the reaction [Aspirin results in increased expression of PTGS2 mRNA] | CTD | PMID:17218764 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | [Quartz co-treated with Ascorbic Acid] results in increased expression of PTGS2 protein | CTD | PMID:17222177 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein] | CTD | PMID:21873648 |
| L-ascorbic acid | multiple interactions | ISO | RGD:731007 | 6480464 | [Quartz co-treated with Ascorbic Acid] results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:17222177 |
| L-ascorbic acid | multiple interactions | ISO | RGD:731007 | 6480464 | Ascorbic Acid inhibits the reaction [JP8 aviation fuel results in increased expression of PTGS2 mRNA] | CTD | PMID:19095747 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17637181 |
| L-dehydroascorbic acid | multiple interactions | EXP | | 6480464 | Dehydroascorbic Acid inhibits the reaction [Blood Glucose affects the expression of PTGS2 protein] | CTD | PMID:15737438 |
| L-methionine | multiple interactions | ISO | RGD:731007 | 6480464 | [Methionine deficiency co-treated with Choline deficiency] results in increased expression of PTGS2 mRNA | CTD | PMID:20697377 |
| lansoprazole | multiple interactions | EXP | | 6480464 | AG-041R inhibits the reaction [lansoprazole results in increased expression of PTGS2 protein] | CTD | PMID:12438555 |
| lansoprazole | increases expression | EXP | | 6480464 | lansoprazole results in increased expression of PTGS2 protein | CTD | PMID:12438555 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of PTGS2 protein | CTD | PMID:16395254 |
| lead diacetate | multiple interactions | EXP | | 6480464 | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [lead acetate results in increased expression of PTGS2 protein] | CTD | PMID:16395254 |
| lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA] | CTD | PMID:19735303 |
| lithium chloride | increases expression | ISO | RGD:731006 | 6480464 | Lithium Chloride results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:15711924 |
| lithium chloride | increases expression | EXP | | 6480464 | Lithium Chloride results in increased expression of PTGS2 mRNA | CTD | PMID:9500967 |
| lithium chloride | increases expression | ISO | RGD:731007 | 6480464 | Lithium Chloride results in increased expression of PTGS2 protein | CTD | PMID:15585669 |
| lithium chloride | increases expression | ISO | RGD:731007 | 6480464 | Lithium Chloride results in increased expression of PTGS2 mRNA | CTD | PMID:19797860 |
| loganin | affects expression | ISO | RGD:731007 | 6480464 | loganin affects the expression of PTGS2 protein | CTD | PMID:21864639 |
| losartan | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [[AGT protein binds to and results in increased localization of AGTR1A protein] which results in increased expression of PTGS2 protein] | CTD | PMID:18267125 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of PTGS2 protein | CTD | PMID:17244722 PMID:21377515 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of PTGS2 protein | CTD | PMID:21377515 PMID:17244722 |
| losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of PTGS2 mRNA | CTD | PMID:17244722 |
| losartan | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [Phenylephrine results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:17244722 |
| lovastatin | decreases expression | ISO | RGD:731006 | 6480464 | Lovastatin results in decreased expression of PTGS2 protein | CTD | PMID:21910007 |
| lutein | multiple interactions | ISO | RGD:731006 | 6480464 | Lutein inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein] | CTD | PMID:20347963 |
| luteolin | multiple interactions | ISO | RGD:731006 | 6480464 | Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 protein]; more ... | CTD | PMID:19557821 |
| LY294002 | multiple interactions | ISO | RGD:731007 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium sulfate results in increased expression of PTGS2] | CTD | PMID:14687664 |
| LY294002 | multiple interactions | ISO | RGD:731007 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [nonylphenol results in increased expression of PTGS2 protein] | CTD | PMID:20954072 |
| LY294002 | multiple interactions | ISO | RGD:731006 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Zinc results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:15980035 |
| LY294002 | multiple interactions | ISO | RGD:731007 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [o,p'-DDT results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18840457 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [arsenite results in increased expression of PTGS2 protein] | CTD | PMID:20377179 |
| LY294002 | multiple interactions | ISO | RGD:731006 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [monomethylarsonous acid results in increased expression of PTGS2 protein] | CTD | PMID:17093206 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in increased expression of PTGS2 protein] | CTD | PMID:17084486 |
| LY294002 | multiple interactions | ISO | RGD:731006 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased expression of PTGS2 protein] | CTD | PMID:20600219 |
| LY294002 | multiple interactions | ISO | RGD:731006 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in increased expression of PTGS2 protein] | CTD | PMID:19084589 |
| LY294002 | multiple interactions | ISO | RGD:731007 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-bromopropane results in increased expression of PTGS2 protein] | CTD | PMID:22353212 |
| LY294002 | multiple interactions | ISO | RGD:731006 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cholesterol-3-beta,5-alpha, 6-beta-triol results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19616084 |
| lycorine | multiple interactions | ISO | RGD:731007 | 6480464 | lycorine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:22155741 |
| manganese atom | increases expression | ISO | RGD:731006 | 6480464 | Manganese results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:17175027 |
| manganese atom | multiple interactions | ISO | RGD:731007 | 6480464 | [Manganese co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA | CTD | PMID:20589745 |
| manganese atom | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:17827730 |
| manganese(0) | increases expression | ISO | RGD:731006 | 6480464 | Manganese results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:17175027 |
| manganese(0) | multiple interactions | ISO | RGD:731007 | 6480464 | [Manganese co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA | CTD | PMID:20589745 |
| manganese(0) | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:17827730 |
| manganese(II) chloride | increases expression | ISO | RGD:731006 | 6480464 | manganese chloride results in increased expression of PTGS2 protein; more ... | CTD | PMID:17175027 |
| manganese(II) chloride | increases expression | ISO | RGD:731006 | 6480464 | manganese chloride results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:17175027 PMID:19084589 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of PTGS2 protein | CTD | PMID:17084486 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of PTGS2 mRNA | CTD | PMID:17084486 PMID:21402727 |
| manganese(II) chloride | multiple interactions | EXP | | 6480464 | 1,3-dimethylthiourea inhibits the reaction [manganese chloride results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17084486 |
| manganese(II) chloride | increases expression | ISO | RGD:731006 | 6480464 | manganese chloride results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:19084589 PMID:17175027 |
| manganese(II) chloride | multiple interactions | ISO | RGD:731006 | 6480464 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [manganese chloride results in increased expression of PTGS2 protein]; more ... | CTD | PMID:19084589 |
| manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of PTGS2 mRNA | CTD | PMID:21402727 |
| mangiferin | multiple interactions | ISO | RGD:731006 | 6480464 | mangiferin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:15161907 PMID:21420233 |
| mangiferin | multiple interactions | ISO | RGD:731006 | 6480464 | mangiferin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:21420233 PMID:15161907 |
| mangiferin | multiple interactions | EXP | | 6480464 | mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:18621015 |
| mangiferin | multiple interactions | EXP | | 6480464 | mangiferin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | CTD | PMID:15381052 |
| mangiferin | affects expression | EXP | | 6480464 | mangiferin affects the expression of PTGS2 mRNA | CTD | PMID:19026997 |
| manoalide | multiple interactions | ISO | RGD:731006 | 6480464 | manoalide inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; more ... | CTD | PMID:7575673 |
| mechlorethamine | increases expression | EXP | | 6480464 | Mechlorethamine results in increased expression of PTGS2 protein | CTD | PMID:20883710 |
| melatonin | multiple interactions | ISO | RGD:731006 | 6480464 | Melatonin inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18588940 |
| melphalan | increases expression | ISO | RGD:731006 | 6480464 | Melphalan results in increased expression of PTGS2 mRNA | CTD | PMID:22363485 |
| mercury dichloride | increases expression | EXP | | 6480464 | Mercuric Chloride results in increased expression of PTGS2 mRNA | CTD | PMID:20228412 |
| methamphetamine | multiple interactions | ISO | RGD:731006 | 6480464 | [[Arachidonic Acid results in increased activity of PTGS2 protein] which results in increased susceptibility to Methamphetamine] which results in increased abundance of 8-oxo-7-hydrodeoxyguanosine; more ... | CTD | PMID:21163909 |
| methamphetamine | increases expression | ISO | RGD:731007 | 6480464 | Methamphetamine results in increased expression of PTGS2 protein | CTD | PMID:10698006 PMID:15718289 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of PTGS2 mRNA | CTD | PMID:15644446 |
| methamphetamine | increases response to substance | ISO | RGD:731007 | 6480464 | PTGS2 protein results in increased susceptibility to Methamphetamine | CTD | PMID:15718289 |
| methamphetamine | increases expression | ISO | RGD:731007 | 6480464 | Methamphetamine results in increased expression of PTGS2 protein | CTD | PMID:15718289 PMID:10698006 |
| methamphetamine | increases response to substance | ISO | RGD:731006 | 6480464 | PTGS2 protein results in increased susceptibility to Methamphetamine | CTD | PMID:21163909 |
| methanol | multiple interactions | ISO | RGD:731006 | 6480464 | [Methanol co-treated with IL1B protein] results in increased expression of PTGS2 mRNA | CTD | PMID:15225597 |
| metoprolol | multiple interactions | EXP | | 6480464 | Metoprolol inhibits the reaction [Isoflurane results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21615343 |
| metoprolol | increases expression | ISO | RGD:731006 | 6480464 | Metoprolol results in increased expression of PTGS2 mRNA | CTD | PMID:17467819 |
| metoprolol | decreases expression | ISO | RGD:731006 | 6480464 | Metoprolol results in decreased expression of PTGS2 mRNA; more ... | CTD | PMID:20424515 |
| mevalonic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]] | CTD | PMID:18612546 |
| midostaurin | multiple interactions | EXP | | 6480464 | 4'-N-benzoylstaurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | CTD | PMID:14613874 |
| misoprostol | increases expression | EXP | | 6480464 | Misoprostol results in increased expression of PTGS2 protein | CTD | PMID:12428691 |
| misoprostol | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Misoprostol results in increased expression of PTGS2 protein]; more ... | CTD | PMID:12428691 |
| mitomycin C | increases expression | ISO | RGD:731006 | 6480464 | Mitomycin results in increased expression of PTGS2 protein | CTD | PMID:15793875 |
| mitomycin C | multiple interactions | ISO | RGD:731006 | 6480464 | Sulindac inhibits the reaction [Mitomycin results in increased expression of PTGS2 protein] | CTD | PMID:15793875 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:731007 | 6480464 | Dexamethasone inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 mRNA] | CTD | PMID:9013627 |
| mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:731006 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 mRNA | CTD | PMID:23360888 |
| mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:731007 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:9013627 |
| montelukast | affects expression | ISO | RGD:731007 | 6480464 | montelukast affects the expression of PTGS2 protein | CTD | PMID:18059327 |
| morphine | increases expression | ISO | RGD:731007 | 6480464 | Morphine results in increased expression of PTGS2 protein | CTD | PMID:16325209 |
| morphine | multiple interactions | EXP | | 6480464 | [nimesulide results in decreased activity of PTGS2 protein] which results in increased susceptibility to Morphine | CTD | PMID:14511336 |
| morphine | multiple interactions | ISO | RGD:731007 | 6480464 | [Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha; more ... | CTD | PMID:16325209 |
| myo-inositol hexakisphosphate | multiple interactions | ISO | RGD:731007 | 6480464 | Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of PTGS2] | CTD | PMID:21154115 |
| myo-inositol hexakisphosphate | affects methylation | ISO | RGD:731007 | 6480464 | Phytic Acid affects the methylation of PTGS2 promoter | CTD | PMID:21154115 |
| myricetin | multiple interactions | ISO | RGD:731006 | 6480464 | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | CTD | PMID:19804834 |
| myricetin | multiple interactions | ISO | RGD:731007 | 6480464 | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:17944529 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731007 | 6480464 | Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased expression of PTGS2 mRNA] which results in increased abundance of Dinoprostone]; more ... | CTD | PMID:16777358 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731007 | 6480464 | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:23268108 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18480072 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of PTGS2 mRNA] | CTD | PMID:21540248 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [acenaphthenequinone results in increased expression of PTGS2 protein] | CTD | PMID:17082565 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] | CTD | PMID:21703343 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [2-aminodiphenyl results in increased expression of PTGS2 protein] | CTD | PMID:22288910 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [Benzene results in increased expression of PTGS2 protein]; more ... | CTD | PMID:21801798 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of PTGS2 protein] | CTD | PMID:19084589 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein] | CTD | PMID:21533553 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731007 | 6480464 | Acetylcysteine inhibits the reaction [JP8 aviation fuel results in increased expression of PTGS2 mRNA] | CTD | PMID:19095747 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731007 | 6480464 | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | CTD | PMID:16024921 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of PTGS2 mRNA] | CTD | PMID:17255567 |
| N-acetyl-L-cysteine | decreases expression | ISO | RGD:731006 | 6480464 | Acetylcysteine results in decreased expression of PTGS2 mRNA | CTD | PMID:16084531 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]; more ... | CTD | PMID:17640750 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [[Formaldehyde co-treated with eugenol, zinc oxide dental cavity lining] results in increased expression of PTGS2 mRNA] | CTD | PMID:15934011 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731006 | 6480464 | Acetylcysteine inhibits the reaction [dentinol results in increased expression of PTGS2 mRNA] | CTD | PMID:15576159 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Nicotine results in increased expression of PTGS2 protein] | CTD | PMID:18068289 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731007 | 6480464 | Acetylcysteine inhibits the reaction [Drugs, Chinese Herbal inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]] | CTD | PMID:19642688 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:731007 | 6480464 | Acetylcysteine inhibits the reaction [cadmium sulfate results in increased expression of PTGS2] | CTD | PMID:14687664 |
| N-ethyl-N-nitrosourea | increases expression | ISO | RGD:731007 | 6480464 | Ethylnitrosourea results in increased expression of PTGS2 | CTD | PMID:21154115 |
| N-ethyl-N-nitrosourea | multiple interactions | ISO | RGD:731007 | 6480464 | Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of PTGS2] | CTD | PMID:21154115 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | increases expression | ISO | RGD:731006 | 6480464 | N-Formylmethionine Leucyl-Phenylalanine results in increased expression of PTGS2 mRNA; more ... | CTD | PMID:12946449 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA] | CTD | PMID:21167192 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of PTGS2 protein] | CTD | PMID:23194824 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of PTGS2 mRNA | CTD | PMID:19539802 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of PTGS2 mRNA | CTD | PMID:21554863 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of PTGS2 protein | CTD | PMID:21554863 PMID:20405173 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of PTGS2 mRNA | CTD | PMID:19539802 more ... |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA | CTD | PMID:20045035 PMID:18164116 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of PTGS2 protein | CTD | PMID:20405173 PMID:21554863 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of PTGS2 mRNA | CTD | PMID:21554863 more ... |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:21554863 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein; more ... | CTD | PMID:20045035 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA | CTD | PMID:18164116 PMID:20045035 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of PTGS2 protein | CTD | PMID:20302851 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:731007 | 6480464 | Diethylnitrosamine results in increased expression of PTGS2 protein | CTD | PMID:20583210 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:731007 | 6480464 | CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] | CTD | PMID:20583210 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] | CTD | PMID:20405173 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | morin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein]; more ... | CTD | PMID:19539802 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of PTGS2 protein | CTD | PMID:20405173 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of PTGS2 mRNA | CTD | PMID:21167192 PMID:19539802 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:731007 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; more ... | CTD | PMID:18449507 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:731007 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | CTD | PMID:9580637 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:731007 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | CTD | PMID:17944529 |
| naproxen | multiple interactions | ISO | RGD:731006 | 6480464 | Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]; more ... | CTD | PMID:15705740 |
| naproxen | decreases activity | EXP | | 6480464 | Naproxen results in decreased activity of PTGS2 protein | CTD | PMID:9258749 |
| naproxen | increases expression | ISO | RGD:731006 | 6480464 | Naproxen results in increased expression of PTGS2 | CTD | PMID:11840453 |
| naproxen | decreases activity | ISO | RGD:731006 | 6480464 | Naproxen results in decreased activity of PTGS2 protein | CTD | PMID:17164136 |
| naproxen | multiple interactions | ISO | RGD:731006 | 6480464 | Naproxen inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | CTD | PMID:15489888 |
| nickel atom | multiple interactions | ISO | RGD:731006 | 6480464 | CAT protein affects the reaction [Nickel results in increased expression of PTGS2]; more ... | CTD | PMID:21486220 |
| nickel atom | increases expression | ISO | RGD:731007 | 6480464 | Nickel results in increased expression of PTGS2 mRNA | CTD | PMID:19839048 |
| nickel atom | increases expression | ISO | RGD:731006 | 6480464 | Nickel results in increased expression of PTGS2 | CTD | PMID:21486220 |
| nickel atom | multiple interactions | ISO | RGD:731007 | 6480464 | Dexamethasone inhibits the reaction [Nickel results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:19839048 |
| nickel dichloride | increases expression | ISO | RGD:731006 | 6480464 | nickel chloride results in increased expression of PTGS2 protein | CTD | PMID:16982623 PMID:17065197 |
| nickel dichloride | increases expression | ISO | RGD:731006 | 6480464 | nickel chloride results in increased expression of PTGS2 protein | CTD | PMID:17065197 PMID:16982623 |
| nickel dichloride | increases expression | ISO | RGD:731006 | 6480464 | nickel chloride results in increased expression of PTGS2 mRNA | CTD | PMID:16982623 more ... |
| nickel dichloride | increases expression | ISO | RGD:731007 | 6480464 | nickel chloride results in increased expression of PTGS2 mRNA | CTD | PMID:17065197 |
| nickel dichloride | increases activity | ISO | RGD:731007 | 6480464 | nickel chloride results in increased activity of PTGS2 promoter | CTD | PMID:16982623 |
| nickel dichloride | increases expression | ISO | RGD:731007 | 6480464 | nickel chloride results in increased expression of PTGS2 protein | CTD | PMID:16982623 PMID:17065197 |
| nickel dichloride | multiple interactions | ISO | RGD:731007 | 6480464 | Dactinomycin inhibits the reaction [nickel chloride results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17065197 |
| nickel dichloride | multiple interactions | ISO | RGD:731007 | 6480464 | IKBKB affects the reaction [nickel chloride results in increased activity of PTGS2 promoter]; more ... | CTD | PMID:16982623 |
| nickel dichloride | increases expression | ISO | RGD:731006 | 6480464 | nickel chloride results in increased expression of PTGS2 mRNA | CTD | PMID:17312168 more ... |
| nickel sulfate | increases expression | ISO | RGD:731006 | 6480464 | nickel sulfate results in increased expression of PTGS2 mRNA | CTD | PMID:16780908 |
| nickel sulfate | multiple interactions | ISO | RGD:731006 | 6480464 | [nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased expression of PTGS2 protein | CTD | PMID:18832182 PMID:20600219 |
| nickel sulfate | multiple interactions | ISO | RGD:731006 | 6480464 | [nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased expression of PTGS2 protein | CTD | PMID:20600219 PMID:18832182 |
| nickel sulfate | multiple interactions | ISO | RGD:731006 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased expression of PTGS2 protein]; more ... | CTD | PMID:20600219 |
| nickel sulfate | multiple interactions | ISO | RGD:731006 | 6480464 | nickel sulfate promotes the reaction [macrophage stimulatory lipopeptide 2 results in increased expression of PTGS2 mRNA] | CTD | PMID:18096868 |
| nickel sulfate | multiple interactions | ISO | RGD:731006 | 6480464 | HIF1A protein promotes the reaction [[macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18832182 |
| nicotinic acid | multiple interactions | ISO | RGD:731007 | 6480464 | [Niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter]] which results in decreased expression of PTGS2 mRNA; more ... | CTD | PMID:21236357 |
| nicotinic acid | multiple interactions | ISO | RGD:731007 | 6480464 | [Niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter]] which results in decreased expression of PTGS2 mRNA | CTD | PMID:21236357 PMID:21236357 |
| nicotinic acid | decreases expression | ISO | RGD:731007 | 6480464 | Niacin results in decreased expression of PTGS2 mRNA; more ... | CTD | PMID:21236357 |
| nifedipine | multiple interactions | ISO | RGD:731006 | 6480464 | [Nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18938131 |
| nifedipine | multiple interactions | ISO | RGD:731006 | 6480464 | Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | CTD | PMID:18388244 |
| nifedipine | multiple interactions | ISO | RGD:731007 | 6480464 | arachidonyltrifluoromethane promotes the reaction [Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]] | CTD | PMID:19063610 |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | nimesulide binds to and results in decreased activity of PTGS2 protein | CTD | PMID:12925531 |
| nimesulide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PTGS2 protein] | CTD | PMID:22940226 |
| nimesulide | decreases activity | EXP | | 6480464 | nimesulide results in decreased activity of PTGS2 protein | CTD | PMID:17564305 PMID:9233713 |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | [nimesulide results in decreased activity of PTGS2 protein] which results in increased expression of CXCL10 mRNA; more ... | CTD | PMID:22561872 |
| nimesulide | decreases activity | ISO | RGD:731006 | 6480464 | nimesulide results in decreased activity of PTGS2 protein | CTD | PMID:17164136 more ... |
| nimesulide | decreases expression | ISO | RGD:731007 | 6480464 | nimesulide results in decreased expression of PTGS2 | CTD | PMID:15892897 more ... |
| nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of PTGS2 protein | CTD | PMID:16194365 more ... |
| nimesulide | decreases expression | ISO | RGD:731007 | 6480464 | nimesulide results in decreased expression of PTGS2 | CTD | PMID:17624748 more ... |
| nimesulide | decreases expression | ISO | RGD:731007 | 6480464 | nimesulide results in decreased expression of PTGS2 | CTD | PMID:20702753 more ... |
| nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of PTGS2 protein | CTD | PMID:16194365 PMID:20668099 |
| nimesulide | decreases expression | ISO | RGD:731007 | 6480464 | nimesulide results in decreased expression of PTGS2 | CTD | PMID:20702753 more ... |
| nimesulide | decreases activity | ISO | RGD:731006 | 6480464 | nimesulide results in decreased activity of PTGS2 protein | CTD | PMID:17431384 more ... |
| nimesulide | decreases expression | ISO | RGD:731007 | 6480464 | nimesulide results in decreased expression of PTGS2 | CTD | PMID:17624748 more ... |
| nimesulide | decreases expression | ISO | RGD:731007 | 6480464 | nimesulide results in decreased expression of PTGS2 | CTD | PMID:15892897 more ... |
| nimesulide | increases expression | ISO | RGD:731006 | 6480464 | nimesulide results in increased expression of PTGS2 protein | CTD | PMID:15482327 PMID:18202791 |
| nimesulide | decreases expression | ISO | RGD:731006 | 6480464 | nimesulide results in decreased expression of PTGS2 mRNA | CTD | PMID:21176579 PMID:15155531 |
| nimesulide | decreases activity | ISO | RGD:731006 | 6480464 | nimesulide results in decreased activity of PTGS2 protein | CTD | PMID:17431384 more ... |
| nimesulide | increases expression | ISO | RGD:731006 | 6480464 | nimesulide results in increased expression of PTGS2 protein | CTD | PMID:18202791 PMID:15482327 |
| nimesulide | decreases activity | ISO | RGD:731006 | 6480464 | nimesulide results in decreased activity of PTGS2 protein | CTD | PMID:17164136 more ... |
| nimesulide | decreases expression | ISO | RGD:731006 | 6480464 | nimesulide results in decreased expression of PTGS2 protein | CTD | PMID:21176579 |
| nimesulide | decreases expression | ISO | RGD:731006 | 6480464 | nimesulide results in decreased expression of PTGS2 mRNA | CTD | PMID:15155531 PMID:21176579 |
| nimesulide | multiple interactions | ISO | RGD:731006 | 6480464 | [nimesulide results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone | CTD | PMID:12417326 |
| nimesulide | multiple interactions | ISO | RGD:731006 | 6480464 | nimesulide inhibits the reaction [PTGS2 results in increased expression of C1QB mRNA] | CTD | PMID:11810182 |
| nimesulide | multiple interactions | ISO | RGD:731006 | 6480464 | nimesulide inhibits the reaction [PTGS2 protein affects the chemical synthesis of and affects the abundance of Dinoprostone]; more ... | CTD | PMID:18297109 |
| nimesulide | multiple interactions | ISO | RGD:731006 | 6480464 | nimesulide inhibits the reaction [PTGS2 results in decreased expression of CDKN2C mRNA] | CTD | PMID:11961048 |
| nimesulide | multiple interactions | ISO | RGD:731006 | 6480464 | nimesulide inhibits the reaction [ciglitazone promotes the reaction [PPARA protein results in increased expression of PTGS2 mRNA]]; more ... | CTD | PMID:11840453 |
| nimesulide | multiple interactions | ISO | RGD:731006 | 6480464 | nimesulide inhibits the reaction [[4-Nitroquinoline-1-oxide co-treated with HRAS] results in increased expression of PTGS2 mRNA] | CTD | PMID:20043093 |
| nimesulide | affects expression | ISO | RGD:731006 | 6480464 | nimesulide affects the expression of PTGS2 mRNA | CTD | PMID:18197933 |
| nimesulide | multiple interactions | EXP | | 6480464 | [nimesulide results in decreased expression of PTGS2] which results in increased activity of anandamide | CTD | PMID:17245358 |
| nimesulide | multiple interactions | EXP | | 6480464 | [nimesulide results in decreased expression of PTGS2 protein] which results in decreased abundance of Dinoprostone | CTD | PMID:16194365 |
| nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of PTGS2 protein | CTD | PMID:20668099 PMID:16194365 |
| nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of PTGS2 | CTD | PMID:17245358 |
| nimesulide | multiple interactions | EXP | | 6480464 | [nimesulide results in decreased activity of PTGS2 protein] which results in increased susceptibility to Morphine | CTD | PMID:14511336 |
| nimesulide | decreases activity | EXP | | 6480464 | nimesulide results in decreased activity of PTGS2 protein | CTD | PMID:17564305 |
| nimesulide | multiple interactions | EXP | | 6480464 | nimesulide promotes the reaction [Carrageenan results in increased expression of PTGS2 protein] | CTD | PMID:17258197 |
| nimesulide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [Dietary Fats results in increased expression of PTGS2 mRNA] | CTD | PMID:19247274 |
| nimesulide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [Dietary Fats results in increased expression of PTGS2] | CTD | PMID:20039930 |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | PTGS2 affects the reaction [nimesulide results in decreased expression of VEGFA protein] | CTD | PMID:15705899 |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | PTGS2 inhibits the reaction [nimesulide results in increased uptake of Hexoses] | CTD | PMID:16447059 |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | [nimesulide results in decreased expression of PTGS2] which results in increased abundance of Arachidonic Acid | CTD | PMID:17624748 |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | [nimesulide results in decreased expression of PTGS2] promotes the reaction [FAAH affects the metabolism of anandamide] | CTD | PMID:20702753 |
| nimesulide | decreases expression | ISO | RGD:731007 | 6480464 | nimesulide results in decreased expression of PTGS2 | CTD | PMID:17382448 more ... |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | nimesulide inhibits the reaction [[soluble tachyzoite antigen, Toxoplasma gondii results in increased expression of PTGS2 mRNA] which results in increased abundance of Dinoprostone]; more ... | CTD | PMID:18305957 |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | nimesulide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:19931610 |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | nimesulide inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:22107987 |
| nimesulide | multiple interactions | ISO | RGD:731007 | 6480464 | [[GW0742 binds to and results in increased activity of PPARD protein] co-treated with [nimesulide results in decreased activity of PTGS2 protein]] results in increased expression of KRT10 mRNA; more ... | CTD | PMID:19748995 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Ouabain results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:18976649 |
| nitric oxide | decreases expression | EXP | | 6480464 | Nitric Oxide deficiency results in decreased expression of PTGS2 mRNA | CTD | PMID:21983654 |
| nitroprusside | multiple interactions | ISO | RGD:731007 | 6480464 | Nitroprusside inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA] | CTD | PMID:16874658 |
| nitroprusside | multiple interactions | ISO | RGD:731006 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | CTD | PMID:18507870 |
| nitroprusside | multiple interactions | ISO | RGD:731006 | 6480464 | Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; more ... | CTD | PMID:17067557 |
| nitroprusside | multiple interactions | ISO | RGD:731007 | 6480464 | [Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | CTD | PMID:17067557 PMID:18507870 |
| nitroprusside | increases expression | ISO | RGD:731007 | 6480464 | Nitroprusside results in increased expression of PTGS2 protein | CTD | PMID:17067557 PMID:18507870 |
| nitroprusside | multiple interactions | ISO | RGD:731007 | 6480464 | Bee Venoms inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; more ... | CTD | PMID:17067557 |
| nitroprusside | multiple interactions | ISO | RGD:731007 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | CTD | PMID:18507870 |
| nitroprusside | increases expression | ISO | RGD:731006 | 6480464 | Nitroprusside results in increased expression of PTGS2 protein | CTD | PMID:17067557 PMID:18507870 |
| nitroprusside | multiple interactions | ISO | RGD:731006 | 6480464 | [Nitroprusside results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | CTD | PMID:17067557 PMID:18507870 |
| nordihydroguaiaretic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Nordihydroguaiaretic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:7575673 |
| nordihydroguaiaretic acid | multiple interactions | ISO | RGD:731006 | 6480464 | Nordihydroguaiaretic Acid inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]] | CTD | PMID:12573452 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [resveratrol results in increased activity of TP53 protein] | CTD | PMID:18446786 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [cumene hydroperoxide results in increased expression of PTGS2 protein] | CTD | PMID:14972014 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | Dexamethasone inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of [IL1B protein results in increased expression of PTGS2 protein]]; more ... | CTD | PMID:12517972 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | Dinoprostone inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]; more ... | CTD | PMID:11095985 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol results in increased expression of PTGS2 protein] | CTD | PMID:16928824 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFA protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:18596194 |
| NS-398 | multiple interactions | EXP | | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | CTD | PMID:11321505 PMID:11321505 |
| NS-398 | multiple interactions | EXP | | 6480464 | Ketorolac inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Carrageenan results in increased expression of PTGS2 protein]] | CTD | PMID:17258197 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] inhibits the reaction [cobaltous chloride results in increased secretion of IL6 protein]; more ... | CTD | PMID:21533553 |
| NS-398 | decreases activity | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein | CTD | PMID:11059772 more ... |
| NS-398 | multiple interactions | EXP | | 6480464 | Dinoprostone results in decreased susceptibility to [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein]; more ... | CTD | PMID:10594344 |
| NS-398 | multiple interactions | EXP | | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol promotes the reaction [MAPK1 protein binds to PTGS2 protein]]; more ... | CTD | PMID:17984113 |
| NS-398 | multiple interactions | EXP | | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide binds to and results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Streptozocin | CTD | PMID:17112505 |
| NS-398 | increases response to substance | ISO | RGD:731006 | 6480464 | PTGS2 protein results in increased susceptibility to N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | CTD | PMID:11059772 PMID:12414664 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | PTGS2 protein affects the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of CDK2 protein] | CTD | PMID:14566837 |
| NS-398 | increases expression | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of PTGS2 protein | CTD | PMID:10485483 more ... |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | CTD | PMID:9705326 |
| NS-398 | decreases activity | EXP | | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein | CTD | PMID:10791687 more ... |
| NS-398 | multiple interactions | EXP | | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; more ... | CTD | PMID:21873648 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | PTGS2 protein inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of CASP9 protein]; more ... | CTD | PMID:12414664 |
| NS-398 | increases expression | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of [IL1B protein results in increased expression of PTGS2 protein]; more ... | CTD | PMID:12517972 |
| NS-398 | multiple interactions | EXP | | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Norepinephrine | CTD | PMID:15834289 |
| NS-398 | decreases expression | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 protein | CTD | PMID:19014992 |
| NS-398 | increases activity | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of PTGS2 protein | CTD | PMID:12517972 |
| NS-398 | decreases expression | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 mRNA | CTD | PMID:15155531 PMID:17709599 |
| NS-398 | multiple interactions | EXP | | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Lipopolysaccharides | CTD | PMID:11321505 |
| NS-398 | multiple interactions | EXP | | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased secretion of Dinoprost; more ... | CTD | PMID:22306367 |
| NS-398 | decreases expression | ISO | RGD:731006 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 | CTD | PMID:15144595 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased susceptibility to o,p'-DDT | CTD | PMID:20678559 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone | CTD | PMID:12417326 |
| NS-398 | multiple interactions | ISO | RGD:731006 | 6480464 | [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein] which affects the susceptibility to Dinitrofluorobenzene | CTD | PMID:21362464 |
| o-cresol | increases expression | EXP | | 6480464 | 2-cresol results in increased expression of PTGS2 mRNA | CTD | PMID:21705299 |
| o-cresol | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PTGS2 mRNA] | CTD | PMID:21705299 |
| O-methylsalicylic acid | multiple interactions | ISO | RGD:731007 | 6480464 | 2-methoxybenzoic acid inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid] | CTD | PMID:12538810 |
| O-methylsalicylic acid | decreases activity | ISO | RGD:731007 | 6480464 | 2-methoxybenzoic acid results in decreased activity of PTGS2 protein | CTD | PMID:12538810 |
| ochratoxin A | increases expression | ISO | RGD:731007 | 6480464 | ochratoxin A results in increased expression of PTGS2 protein | CTD | PMID:18647641 |
| ochratoxin A | multiple interactions | ISO | RGD:731007 | 6480464 | ochratoxin A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | CTD | PMID:18647641 |
| ofloxacin | increases expression | EXP | | 6480464 | Ofloxacin results in increased expression of PTGS2 mRNA | CTD | PMID:20688128 |
| okadaic acid | increases expression | ISO | RGD:731007 | 6480464 | Okadaic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:8989914 PMID:9013627 |
| okadaic acid | increases expression | ISO | RGD:731007 | 6480464 | Okadaic Acid results in increased expression of PTGS2 protein | CTD | PMID:9013627 |
| oleanolic acid | increases expression | ISO | RGD:731007 | 6480464 | Oleanolic Acid results in increased expression of PTGS2 mRNA | CTD | PMID:18706400 |
| oleoyl ethanolamide | decreases expression | ISO | RGD:731007 | 6480464 | N-oleoylethanolamine results in decreased expression of PTGS2 protein | CTD | PMID:17906680 |
| oroxylin A | multiple interactions | ISO | RGD:731007 | 6480464 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:22101131 |
| ouabain | multiple interactions | EXP | | 6480464 | [Ouabain results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:18976649 |
| ouabain | increases expression | EXP | | 6480464 | Ouabain results in increased expression of PTGS2 protein | CTD | PMID:18976649 |
| ozone | decreases activity | ISO | RGD:731006 | 6480464 | Ozone results in decreased activity of PTGS2 protein | CTD | PMID:9176252 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of PTGS2 protein | CTD | PMID:22727909 |
| ozone | increases expression | ISO | RGD:731007 | 6480464 | Ozone results in increased expression of PTGS2 mRNA | CTD | PMID:21543283 PMID:18926814 |
| ozone | increases expression | ISO | RGD:731007 | 6480464 | Ozone results in increased expression of PTGS2 mRNA | CTD | PMID:18926814 PMID:21543283 |
| ozone | multiple interactions | ISO | RGD:731007 | 6480464 | TTPA protein affects the reaction [Ozone results in increased expression of PTGS2 mRNA] | CTD | PMID:19555225 |
| ozone | increases expression | ISO | RGD:731007 | 6480464 | Ozone results in increased expression of PTGS2 mRNA | CTD | PMID:18926814 |
| ozone | increases expression | ISO | RGD:731007 | 6480464 | Ozone results in increased expression of PTGS2 protein | CTD | PMID:15064226 |
| ozone | multiple interactions | ISO | RGD:731007 | 6480464 | NFKB1 gene mutant form inhibits the reaction [Ozone results in increased expression of PTGS2 protein] | CTD | PMID:15064226 |
| ozone | multiple interactions | ISO | RGD:731007 | 6480464 | indole-5-carboxamide inhibits the reaction [Ozone results in increased expression of PTGS2 mRNA] | CTD | PMID:18926814 |
| ozone | multiple interactions | ISO | RGD:731006 | 6480464 | [Ozone co-treated with Particulate Matter] results in increased expression of PTGS2 mRNA | CTD | PMID:15513908 |
| paclitaxel | multiple interactions | ISO | RGD:731006 | 6480464 | Curcumin inhibits the reaction [Paclitaxel results in increased expression of PTGS2 protein]; more ... | CTD | PMID:16243823 |
| paclitaxel | multiple interactions | ISO | RGD:731006 | 6480464 | ciglitazone inhibits the reaction [Paclitaxel results in increased expression of PTGS2 protein] | CTD | PMID:11278336 |
| paclitaxel | increases expression | ISO | RGD:731006 | 6480464 | Paclitaxel results in increased expression of PTGS2 protein | CTD | PMID:11278336 |
| paclitaxel | increases expression | ISO | RGD:731007 | 6480464 | Paclitaxel results in increased expression of PTGS2 mRNA | CTD | PMID:11123339 |
| paclitaxel | multiple interactions | ISO | RGD:731007 | 6480464 | CD14 protein affects the reaction [Paclitaxel results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:11123339 |
| paclitaxel | decreases expression | ISO | RGD:731006 | 6480464 | Paclitaxel results in decreased expression of PTGS2 protein | CTD | PMID:15907983 |
| paclitaxel | multiple interactions | ISO | RGD:731006 | 6480464 | PTGS2 protein results in decreased susceptibility to [Platinum co-treated with Paclitaxel] | CTD | PMID:16831230 |
| paracetamol | increases expression | ISO | RGD:731007 | 6480464 | Acetaminophen results in increased expression of PTGS2 mRNA | CTD | PMID:12051698 PMID:11743745 |
| paracetamol | increases activity | ISO | RGD:731007 | 6480464 | Acetaminophen results in increased activity of PTGS2 protein | CTD | PMID:21277885 |
| paracetamol | decreases response to substance | ISO | RGD:731007 | 6480464 | PTGS2 protein results in decreased susceptibility to Acetaminophen | CTD | PMID:11743745 PMID:21277885 |
| paracetamol | multiple interactions | ISO | RGD:731007 | 6480464 | PTGS2 gene mutant form promotes the reaction [Acetaminophen results in increased expression of TNF protein] | CTD | PMID:21277885 |
| paracetamol | multiple interactions | ISO | RGD:731007 | 6480464 | CAV1 affects the reaction [Acetaminophen results in increased expression of PTGS2 protein] | CTD | PMID:20100502 |
| paracetamol | increases expression | ISO | RGD:731007 | 6480464 | Acetaminophen results in increased expression of PTGS2 protein | CTD | PMID:20100502 |
| paracetamol | increases expression | ISO | RGD:731007 | 6480464 | Acetaminophen results in increased expression of PTGS2 mRNA | CTD | PMID:11743745 more ... |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PTGS2 mRNA | CTD | PMID:16172162 |
| paracetamol | decreases response to substance | ISO | RGD:731007 | 6480464 | PTGS2 protein results in decreased susceptibility to Acetaminophen | CTD | PMID:11743745 |
| paracetamol | increases expression | ISO | RGD:731007 | 6480464 | Acetaminophen results in increased expression of PTGS2 mRNA | CTD | PMID:11743745 PMID:12051698 |
| paracetamol | multiple interactions | ISO | RGD:731007 | 6480464 | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of DNAJA1 mRNA]; more ... | CTD | PMID:11743745 |
| paracetamol | multiple interactions | ISO | RGD:731007 | 6480464 | Acetaminophen inhibits the reaction [Diclofenac results in increased expression of PTGS2 protein] | CTD | PMID:15626590 |
| paracetamol | increases expression | ISO | RGD:731006 | 6480464 | Acetaminophen results in increased expression of PTGS2 mRNA | CTD | PMID:17175104 |
| paracetamol | decreases activity | ISO | RGD:731006 | 6480464 | Acetaminophen results in decreased activity of PTGS2 protein | CTD | PMID:11113024 |
| paracetamol | multiple interactions | ISO | RGD:731006 | 6480464 | Acetaminophen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]; more ... | CTD | PMID:15705740 |
| paraquat | increases expression | ISO | RGD:731006 | 6480464 | Paraquat results in increased expression of PTGS2 mRNA; |